Olivier Hermine
#103,745
Most Influential Person Now
Researcher
Olivier Hermine's AcademicInfluence.com Rankings
Olivier Herminephilosophy Degrees
Philosophy
#4149
World Rank
#6553
Historical Rank
Logic
#1674
World Rank
#2485
Historical Rank
Download Badge
Philosophy
Olivier Hermine's Degrees
- PhD Biomedical Sciences Université Paris Cité
- Doctorate Medicine Université Paris Cité
Why Is Olivier Hermine Influential?
(Suggest an Edit or Addition)Olivier Hermine's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study (2009) (822)
- Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. (2002) (800)
- Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response Criteria (2007) (695)
- Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial. (2020) (624)
- Transforming Growth Factor β1, in the Presence of Granulocyte/Macrophage Colony-stimulating Factor and Interleukin 4, Induces Differentiation of Human Peripheral Blood Monocytes into Dendritic Langerhans Cells (1998) (550)
- Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. (2009) (499)
- Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA). (1996) (484)
- Treatment of older patients with mantle-cell lymphoma. (2012) (453)
- TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. (1999) (438)
- CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. (2001) (433)
- Caspase Activation Is Required for Terminal Erythroid Differentiation (2001) (432)
- Gene Therapy in Patients with Transfusion‐Dependent β‐Thalassemia (2018) (425)
- Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. (2006) (416)
- Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study. (2006) (400)
- Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis. (2021) (391)
- Platelet formation is the consequence of caspase activation within megakaryocytes. (2002) (345)
- Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML) (2006) (344)
- Specific involvement of caspases in the differentiation of monocytes into macrophages. (2002) (342)
- Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT (2009) (336)
- Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. (2009) (333)
- Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study. (2011) (330)
- Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes. (2010) (318)
- Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. (2010) (311)
- ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment? (2017) (309)
- Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis. (2016) (308)
- WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12. (2005) (305)
- Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network (2016) (289)
- NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells. (2008) (287)
- A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response (2002) (282)
- ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma. (2013) (280)
- Autosomal Dominant STAT3 Deficiency and Hyper-IgE Syndrome: Molecular, Cellular, and Clinical Features From a French National Survey (2012) (274)
- Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. (2005) (268)
- Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases. (2005) (266)
- Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. (1995) (265)
- A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies. (2007) (265)
- Rituximab after Autologous Stem‐Cell Transplantation in Mantle‐Cell Lymphoma (2017) (261)
- Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology. (2016) (258)
- Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1 (2007) (258)
- Masitinib is safe and effective for the treatment of canine mast cell tumors. (2008) (258)
- Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths (2021) (257)
- An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia (2014) (253)
- Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network. (2016) (248)
- Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study. (2010) (248)
- High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis. (2007) (245)
- Vital functions for lethal caspases (2005) (239)
- Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene. (2007) (236)
- The Enteropathy Associated With Common Variable Immunodeficiency: The Delineated Frontiers With Celiac Disease (2010) (235)
- CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d'Etude des Lymphomes de l'Adulte. (2013) (229)
- Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19 (2020) (225)
- Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders. (2001) (222)
- Prognostic factors for survival and response after high‐dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients (1998) (222)
- Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2017) (210)
- Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma. (2002) (203)
- Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry (2009) (203)
- Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity? (2005) (199)
- KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis (2015) (192)
- Arsenic trioxide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells. (1999) (192)
- Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation. (2014) (188)
- Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies (2017) (187)
- Neuropilin-1 Is Involved in Human T-Cell Lymphotropic Virus Type 1 Entry (2006) (186)
- Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. (2007) (185)
- Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms (2003) (184)
- The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation. (2010) (183)
- Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future. (2017) (181)
- Autoimmune Thrombocytopenic Purpura and Common Variable Immunodeficiency: Analysis of 21 Cases and Review of the Literature (2004) (180)
- Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL). (2009) (179)
- Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey. (2012) (177)
- The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells. (2008) (174)
- Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies. (2015) (170)
- Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature. (2006) (168)
- Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia (2010) (167)
- Phenotypic and Genotypic Characteristics of Mastocytosis According to the Age of Onset (2008) (164)
- Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype (2001) (163)
- Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia. (2009) (162)
- Mortality of French participants in the Tour de France (1947-2012). (2013) (160)
- Immunosuppressive role of semaphorin‐3A on T cell proliferation is mediated by inhibition of actin cytoskeleton reorganization (2006) (159)
- Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trials. (2012) (156)
- Gain-of-Function Mutations in the Extracellular Domain of KIT Are Common in Canine Mast Cell Tumors (2008) (154)
- Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia. (2003) (154)
- How I treat adult T-cell leukemia/lymphoma. (2011) (153)
- Women and Men in Sport Performance: The Gender Gap has not Evolved since 1983. (2010) (151)
- Prognostic Significance of bcl-2 Protein Expression in Aggressive Non-Hodgkin's Lymphoma (1996) (150)
- Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs. (2006) (150)
- The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia (2012) (150)
- Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature review. (2003) (149)
- Transforming growth factor inhibits erythropoiesis by blocking proliferation and accelerating differentiation of erythroid progenitors. (2000) (148)
- Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study (2002) (147)
- L-asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature. (2009) (146)
- Type I interferon-mediated autoinflammation due to DNase II deficiency (2017) (144)
- Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis (2014) (144)
- A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation. (2011) (144)
- The Spectrum of Type I Cryoglobulinemia Vasculitis (2013) (143)
- Systemic mastocytosis and bone involvement in a cohort of 75 patients (2010) (143)
- Arsenic-interferon-α–triggered apoptosis in HTLV-I transformed cells is associated with Tax down-regulation and reversal of NF-κB activation (2000) (142)
- Proliferating cell nuclear antigen acts as a cytoplasmic platform controlling human neutrophil survival (2010) (142)
- Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection. (2016) (140)
- New therapeutic approaches for adult T-cell leukaemia. (2004) (139)
- Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1 (2021) (139)
- Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities. (2008) (139)
- Primary lymphoma of the liver: Clinical‐pathological features and relationship with HCV infection in French patients (2003) (139)
- Case-Control Cohort Study of Patients' Perceptions of Disability in Mastocytosis (2008) (138)
- Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2014) (137)
- Paediatric mastocytosis: a systematic review of 1747 cases (2015) (137)
- Neuropilin‐1 is not a marker of human Foxp3+ Treg (2009) (137)
- Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease. (2010) (136)
- Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling. (2008) (136)
- Common variable immunodeficiency is associated with defective functions of dendritic cells. (2004) (136)
- Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network. (2014) (135)
- Masitinib, a c‐kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid‐dependent asthmatics (2009) (133)
- Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence. (2006) (132)
- FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function. (2009) (131)
- Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease. (2014) (130)
- Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination. (2003) (129)
- Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report (2019) (127)
- Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma. (2004) (126)
- Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation study. (2009) (125)
- FLT3 and MLL intragenic abnormalities in AML reflect a common category of genotoxic stress. (2003) (124)
- Efficacy and safety of rituximab in common variable immunodeficiency‐associated immune cytopenias: a retrospective multicentre study on 33 patients (2011) (124)
- Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature. (2013) (123)
- Hematopoietic stem-cell transplantation for advanced systemic mastocytosis. (2014) (123)
- High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma. (2015) (123)
- Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial (2011) (122)
- A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma. (2002) (122)
- Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by overexpression of the chemokine I-309. (2001) (121)
- Bortezomib as the Sole Post‐Renal Transplantation Desensitization Agent Does Not Decrease Donor‐Specific Anti‐HLA Antibodies (2010) (120)
- Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome. (2019) (118)
- A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency. (2012) (116)
- Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype. (2011) (116)
- Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST). (2010) (116)
- Natural antibodies sustain differentiation and maturation of human dendritic cells. (2004) (115)
- Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial (2019) (114)
- Enteropathy associated T cell lymphoma in celiac disease: A large retrospective study☆ (2013) (113)
- Control of human thymocyte migration by Neuropilin-1/Semaphorin-3A-mediated interactions (2007) (113)
- International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis. (2013) (113)
- A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia. (2020) (110)
- Tax ubiquitylation and sumoylation control critical cytoplasmic and nuclear steps of NF-kappaB activation. (2006) (110)
- Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5). (2016) (110)
- HSP70 sequestration by free α-globin promotes ineffective erythropoiesis in β-thalassaemia (2014) (108)
- Ineffective Erythropoiesis in β-Thalassemia (2013) (107)
- Arsenic/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells. (2003) (107)
- Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma. (2018) (106)
- Human T-cell lymphotropic virus oncoprotein Tax represses TGF-beta 1 signaling in human T cells via c-Jun activation: a potential mechanism of HTLV-I leukemogenesis. (2002) (103)
- Galectin-1 and semaphorin-3A are two soluble factors conferring T-cell immunosuppression to bone marrow mesenchymal stem cell. (2010) (102)
- Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis (2016) (102)
- Reducing the global burden of HTLV‐1 infection: An agenda for research and action (2017) (102)
- Overexpression of the heat-shock protein 70 is associated to imatinib resistance in chronic myeloid leukemia (2007) (102)
- Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study (2012) (101)
- Early posttransplantation donor-derived invariant natural killer T-cell recovery predicts the occurrence of acute graft-versus-host disease and overall survival. (2012) (101)
- Durable remission after aggressive chemotherapy for very late post-kidney transplant lymphoproliferation: A report of 16 cases observed in a single center. (2000) (99)
- Proinflammatory Environment Dictates the IL-17–Producing Capacity of Human Invariant NKT Cells (2011) (97)
- Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis. (2015) (97)
- Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: A phase 2a study (2010) (95)
- Early high-dose erythropoietin therapy and hypothermia after out-of-hospital cardiac arrest: a matched control study. (2008) (94)
- Common variable immunodeficiency: the immune system in chaos. (2005) (94)
- Epidemiology and Outcome of Invasive Fungal Diseases in Patients With Chronic Granulomatous Disease: A Multicenter Study in France (2011) (94)
- Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B‐cell non‐Hodgkin lymphomas, ANRS HC‐13 lympho‐C study (2015) (93)
- The Citius End: World Records Progression Announces the Completion of a Brief Ultra-Physiological Quest (2008) (93)
- Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network. (2018) (93)
- Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia (2010) (92)
- Reduced expression of FOXP3 and regulatory T-cell function in severe forms of early-onset autoimmune enteropathy. (2010) (92)
- Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1–associated adult T-cell leukemia (2010) (91)
- Faculty Opinions recommendation of Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts. (2019) (90)
- Modulation of Dendritic Cell Maturation and Function by B Lymphocytes1 (2005) (89)
- Mast cell leukemia. (2013) (89)
- Gastrointestinal involvement and manifestations in systemic mastocytosis (2010) (87)
- Recurrent partial trisomy 1q22-q44 in clonal intraepithelial lymphocytes in refractory celiac sprue. (2003) (87)
- Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid Leukemia. (2015) (87)
- Efficacy and mechanism of action of the proteasome inhibitor PS-341 in T-cell lymphomas and HTLV-I associated adult T-cell leukemia/lymphoma (2005) (86)
- Impaired Antibody Affinity Maturation Process Characterizes a Subset of Patients with Common Variable Immunodeficiency1 (2000) (86)
- TLX homeodomain oncogenes mediate T cell maturation arrest in T-ALL via interaction with ETS1 and suppression of TCRα gene expression. (2012) (86)
- Activity of fludarabine in previously treated Waldenström's macroglobulinemia: a report of 71 cases. Groupe Coopératif Macroglobulinémie. (1998) (86)
- Effectiveness of Tocilizumab in Patients Hospitalized With COVID-19: A Follow-up of the CORIMUNO-TOCI-1 Randomized Clinical Trial. (2021) (85)
- Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas (2019) (84)
- In aggressive forms of mastocytosis, TET2 loss cooperates with c-KITD816V to transform mast cells. (2012) (82)
- Sequential chemotherapy regimens followed by high-dose therapy with stem cell transplantation in mantle cell lymphoma: an update of a prospective study. (2004) (82)
- High Dose Epoetin Beta in the First Weeks Following Renal Transplantation and Delayed Graft Function: Results of the Neo‐PDGF Study (2010) (81)
- Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal. (2014) (80)
- Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study (2017) (80)
- Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia/lymphoma patients. (1996) (79)
- Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS. (2018) (79)
- Syndrome d’activation macrophagique (2002) (79)
- The role of mast cells in cancers (2015) (79)
- Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors. (2010) (79)
- Ubiquitylated Tax targets and binds the IKK signalosome at the centrosome (2008) (76)
- Body-cavity-based lymphoma in an HIV-seronegative patient without Kaposi's sarcoma-associated herpesvirus-like DNA sequences. (1996) (76)
- Evaluation of 12- and 24-month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors. (2010) (75)
- Arsenic-interferon-alpha-triggered apoptosis in HTLV-I transformed cells is associated with tax down-regulation and reversal of NF-kappa B activation. (2000) (75)
- Caractéristiques des anémies hémolytiques auto-immunes de l’adulte : analyse rétrospective d’une série de 83 patients (2001) (75)
- A clinical and pharmacological study of arsenic trioxide in advanced multiple myeloma patients (2004) (75)
- Phase 1 dose-escalation study of oral tyrosine kinase inhibitor masitinib in advanced and/or metastatic solid cancers. (2009) (75)
- G-CSF mobilizes CD34+ regulatory monocytes that inhibit graft-versus-host disease (2015) (74)
- The telomere/telomerase system in autoimmune and systemic immune-mediated diseases. (2010) (74)
- A New clinical score for disease activity in Langerhans cell histiocytosis (2004) (74)
- Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2017) (73)
- Pulmonary Hypertension Associated with Myeloproliferative Disorders: A Retrospective Study of Ten Cases (2007) (73)
- Prevention of infections during primary immunodeficiency. (2014) (71)
- Non HCV-related infectious cryoglobulinemia vasculitis: Results from the French nationwide CryoVas survey and systematic review of the literature. (2015) (71)
- Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia (2015) (71)
- IL-17-producing invariant NKT cells in lymphoid organs are recent thymic emigrants identified by neuropilin-1 expression. (2011) (70)
- Association of Killer Cell Immunoglobulin-Like Receptor Genes with Hodgkin's Lymphoma in a Familial Study (2007) (70)
- A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients (2004) (70)
- Current concepts regarding the HTLV-1 receptor complex (2010) (70)
- Hodgkin lymphoma-associated hemophagocytic syndrome: a disorder strongly correlated with Epstein-Barr virus. (2008) (69)
- HSP27 controls GATA-1 protein level during erythroid cell differentiation. (2010) (69)
- Rapamycin inhibits growth and survival of D816V-mutated c-kit mast cells. (2006) (69)
- Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives. (2001) (69)
- Red blood cell phosphatidylserine exposure is responsible for increased erythrocyte adhesion to endothelium in central retinal vein occlusion (2011) (68)
- Evidence against a direct cytotoxic effect of alpha interferon and zidovudine in HTLV-I associated adult T cell leukemia/lymphoma (2000) (68)
- Masitinib Combined with Standard Gemcitabine Chemotherapy: In Vitro and In Vivo Studies in Human Pancreatic Tumour Cell Lines and Ectopic Mouse Model (2010) (68)
- Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study (2009) (67)
- Characteristic Pattern of Chromosomal Imbalances in Posttransplantation Lymphoproliferative Disorders: Correlation with Histopathological Subcategories and EBV Status (2005) (67)
- A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response (2003) (67)
- Depression in Patients with Mastocytosis: Prevalence, Features and Effects of Masitinib Therapy (2011) (67)
- Molecular Aspects of HTLV-1 Entry: Functional Domains of the HTLV-1 Surface Subunit (SU) and Their Relationships to the Entry Receptors (2011) (67)
- Analysis of interleukin-27 (EBI3/p28) expression in Epstein-Barr virus- and human T-cell leukemia virus type 1-associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cells. (2005) (66)
- Human Bone Marrow Adipocytes Block Granulopoiesis Through Neuropilin‐1‐Induced Granulocyte Colony‐Stimulating Factor Inhibition (2008) (66)
- A Review of New Findings in Adult T-cell Leukemia–Lymphoma: A Focus on Current and Emerging Treatment Strategies (2018) (66)
- Economic evaluation of immunoglobulin replacement in patients with primary antibody deficiencies (2009) (66)
- Hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: experience of the French neutropenia registry (2005) (66)
- Gastrointestinal manifestations in mastocytosis: a study of 83 patients. (2013) (66)
- Exploiting an Asp-Glu “switch” in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia (2018) (65)
- Human herpesvirus 8 (HHV‐8)‐associated peritoneal primary effusion lymphoma (PEL) in two HIV‐negative elderly patients (2004) (65)
- Cis-perturbation of cancer drivers by the HTLV-1/BLV proviruses is an early determinant of leukemogenesis (2017) (65)
- Human T-cell lymphotropic virus type 1-transformed cells induce angiogenesis and establish functional gap junctions with endothelial cells. (2002) (65)
- Current treatment options in patients with mastocytosis: status in 2015 and future perspectives (2015) (65)
- The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma (2014) (65)
- Free HTLV-1 induces TLR7-dependent innate immune response and TRAIL relocalization in killer plasmacytoid dendritic cells. (2010) (65)
- Defective nuclear localization of Hsp70 is associated with dyserythropoiesis and GATA-1 cleavage in myelodysplastic syndromes. (2012) (64)
- Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: a mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies. (2011) (64)
- ASXL1 but Not TET2 Mutations Adversely Impact Overall Survival of Patients Suffering Systemic Mastocytosis with Associated Clonal Hematologic Non-Mast-Cell Diseases (2014) (64)
- Spontaneous abrogation of the G₂DNA damage checkpoint has clinical benefits but promotes leukemogenesis in Fanconi anemia patients. (2011) (64)
- Loss of the ex vivo but not the reinducible CD8+ T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/lymphoma (2004) (64)
- Impaired Transferrin Receptor Palmitoylation and Recycling in Neurodegeneration with Brain Iron Accumulation. (2018) (63)
- Polymeric IgA1 controls erythroblast proliferation and accelerates erythropoiesis recovery in anemia (2010) (63)
- Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis (2016) (63)
- Evidence for Cognitive Impairment in Mastocytosis: Prevalence, Features and Correlations to Depression (2012) (62)
- Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network (2013) (62)
- Molecular defects in mastocytosis: KIT and beyond KIT. (2014) (62)
- Rapamycin Combined with TGF-β Converts Human Invariant NKT Cells into Suppressive Foxp3+ Regulatory Cells (2012) (62)
- Granulocyte-macrophage colony-stimulating factor and erythropoietin act competitively to induce two different programs of differentiation in the human pluripotent cell line UT-7. (1992) (62)
- Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts (2020) (61)
- Efficacy of lenalidomide in POEMS syndrome: A retrospective study of 20 patients (2013) (61)
- Fludarabine: an effective treatment in patients with splenic lymphoma with villous lymphocytes (2000) (61)
- Outcome of patients with HTLV-1-associated adult T-cell leukemia/lymphoma after SCT: a retrospective study by the EBMT LWP (2014) (61)
- Frequent and Widespread Vascular Abnormalities in Human Signal Transducer and Activator of Transcription 3 Deficiency (2012) (61)
- First experience of autologous peripheral blood stem cell mobilization with biosimilar granulocyte colony- stimulating factor (2011) (61)
- Mutations in ACTRT1 and its enhancer RNA elements lead to aberrant activation of Hedgehog signaling in inherited and sporadic basal cell carcinomas (2017) (60)
- Pulmonary manifestations in adult patients with chronic granulomatous disease (2015) (60)
- Retinoic acid therapy in “degenerative‐like” neuro‐langerhans cell histiocytosis: A prospective pilot study (2004) (59)
- ATL response to arsenic/interferon therapy is triggered by SUMO/PML/RNF4-dependent Tax degradation. (2015) (59)
- Human T-Cell Lymphotropic Virus Type I-Infected Cells Extravasate through the Endothelial Barrier by a Local Angiogenesis-Like Mechanism (2004) (58)
- Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer (2010) (58)
- Reversibility of pulmonary arterial hypertension in HIV/HHV8-associated Castleman's disease (2005) (57)
- International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study. (2019) (57)
- Ineffective erythropoiesis with reduced red blood cell survival in serotonin-deficient mice (2011) (57)
- Thalidomide therapy induces response in relapsed mantle cell lymphoma (2003) (57)
- An autocrine role for erythropoietin in mouse hematopoietic cell differentiation. (1991) (56)
- Sotatercept, a novel transforming growth factor β ligand trap, improves anemia in β-thalassemia: a phase II, open-label, dose-finding study (2018) (56)
- Distinct deregulation of the hypoxia inducible factor by PHD2 mutants identified in germline DNA of patients with polycythemia (2012) (56)
- AK2 deficiency compromises the mitochondrial energy metabolism required for differentiation of human neutrophil and lymphoid lineages (2015) (55)
- Toll-like receptor control of glucocorticoid-induced apoptosis in human plasmacytoid predendritic cells (pDCs). (2010) (55)
- Recent advances in adult T-cell leukemia therapy: focus on a new anti-transferrin receptor monoclonal antibody (2008) (55)
- SRSF2-p95 hotspot mutation is highly associated with advanced forms of mastocytosis and mutations in epigenetic regulator genes (2014) (55)
- Small intestinal CD4+ T-cell lymphoma is a heterogenous entity with common pathology features. (2014) (55)
- Antioxidant and Membrane Binding Properties of Serotonin Protect Lipids from Oxidation. (2017) (54)
- Angio-immunoblastic T cell lymphoma (AILD-TL) rich in large B cells and associated with Epstein–Barr virus infection. A different subtype of AILD-TL? (2002) (54)
- Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: A randomized controlled open-label trial (2014) (53)
- Tax ubiquitylation and SUMOylation control the dynamic shuttling of Tax and NEMO between Ubc9 nuclear bodies and the centrosome (2011) (53)
- Extrahepatic cancers and chronic HCV infection (2018) (53)
- Complex karyotype in mantle cell lymphoma is a strong prognostic factor for the time to treatment and overall survival, independent of the MCL international prognostic index (2014) (53)
- Subcutaneous Panniculitis-like T-cell Lymphoma: Immunosuppressive Drugs Induce Better Response than Polychemotherapy. (2017) (53)
- From hepatitis C virus infection to B-cell lymphoma (2018) (52)
- High Level of Glutathione-S-Transferase π Expression in Mantle Cell Lymphomas (2004) (52)
- Athlete Atypicity on the Edge of Human Achievement: Performances Stagnate after the Last Peak, in 1988 (2010) (51)
- Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice (2016) (51)
- Spherocytic shift of red blood cells during storage provides a quantitative whole cell–based marker of the storage lesion (2017) (51)
- Evidence for mast cells contributing to neuromuscular pathology in an inherited model of ALS. (2017) (50)
- Hepatitis C virus core variants isolated from liver tumor but not from adjacent non-tumor tissue interact with Smad3 and inhibit the TGF-β pathway (2005) (50)
- Paradoxical secondary polycythemia in von Hippel-Lindau patients treated with anti-vascular endothelial growth factor receptor therapy. (2002) (50)
- Midostaurin in Advanced Systemic Mastocytosis. (2016) (50)
- Prognostic Significance of New Immunohistochemical Markers in Refractory Classical Hodgkin Lymphoma: A Study of 59 Cases (2009) (50)
- Hepatitis C virus core variants isolated from liver tumor but not from adjacent non-tumor tissue interact with Smad3 and inhibit the TGF-beta pathway. (2005) (50)
- Detection of clonal CD34+19+ progenitors in bone marrow of BCL2-IgH-positive follicular lymphoma patients. (1995) (49)
- A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer (2015) (49)
- Efficacy of 5‐Azacytidine in a TET2 mutated angioimmunoblastic T cell lymphoma (2015) (48)
- Chronic Granulomatous Disease in Patients Reaching Adulthood: A Nationwide Study in France (2017) (48)
- Bone complications of mastocytosis: a link between clinical and biological characteristics. (2013) (48)
- Mogamulizumab versus investigator’s choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma (2018) (48)
- Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: data from 242 cases included in the CryoVas survey (2012) (48)
- Midostaurin: a magic bullet that blocks mast cell expansion and activation (2017) (47)
- Tour de France, Giro, Vuelta, and classic European races show a unique progression of road cycling speed in the last 20 years (2010) (46)
- Arsenic trioxide induces accumulation of cytotoxic levels of ceramide in acute promyelocytic leukemia and adult T-cell leukemia/lymphoma cells through de novo ceramide synthesis and inhibition of glucosylceramide synthase activity. (2007) (46)
- Pediatric-onset Evans syndrome: Heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations. (2018) (46)
- Mast cell leukemia: identification of a new c‐Kit mutation, dup(501‐502), and response to masitinib, a c‐Kit tyrosine kinase inhibitor (2012) (46)
- Upfront allogeneic stem cell transplantation after reduced-intensity/nonmyeloablative conditioning for patients with myelodysplastic syndrome: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire. (2014) (44)
- How to manage mantle cell lymphoma (2014) (44)
- Protective effect of IgM against colonization of the respiratory tract by nontypeable Haemophilus influenzae in patients with hypogammaglobulinemia. (2012) (44)
- Early High-Dose Erythropoietin Therapy After Out-of-Hospital Cardiac Arrest: A Multicenter, Randomized Controlled Trial. (2016) (44)
- Heart Rate and Risk of Cancer Death in Healthy Men (2011) (44)
- Minimal residual disease monitoring by 8-color flow cytometry in mantle cell lymphoma: an EU-MCL and LYSA study (2016) (44)
- Semaphorin 3F and Neuropilin-2 Control the Migration of Human T-Cell Precursors (2014) (43)
- Dramatic clinical efficacy of cladribine in Rosai-Dorfman disease and evolution of the cytokine profile: towards a new therapeutic approach. (2006) (43)
- Structure-based discovery of a small non-peptidic Neuropilins antagonist exerting in vitro and in vivo anti-tumor activity on breast cancer model. (2014) (43)
- Rituximab Maintenance after Autologous Stem Cell Transplantation Prolongs Survival in Younger Patients with Mantle Cell Lymphoma: Final Results of the Randomized Phase 3 LyMa Trial of the Lysa/Goelams Group (2016) (42)
- [Characteristics of autoimmune hemolytic anemia in adults: retrospective analysis of 83 cases]. (2002) (42)
- Neuropsychological features of adult mastocytosis. (2014) (41)
- Enteropathy-associated T-cell lymphoma: a review on clinical presentation, diagnosis, therapeutic strategies and perspectives. (2010) (41)
- Normal and pathological erythropoiesis in adults: from gene regulation to targeted treatment concepts (2018) (41)
- Feline low-grade alimentary lymphoma: an emerging entity and a potential animal model for human disease (2018) (41)
- Lack of evidence of HTLV-I/II infection in T CD8 malignant or reactive lymphoproliferative disorders in France: a serological and/or molecular study of 169 cases. (1995) (40)
- Therapeutic Options for Adult T-Cell Leukemia/Lymphoma (2013) (40)
- Safety of masitinib mesylate in healthy cats. (2011) (40)
- 818 Excess Risk of Lymphoproliferative Disorders (LPD) in Inflammatory Bowel Diseases (IBD): Interim Results of the Cesame Cohort (2008) (40)
- From Oxford to Hawaii Ecophysiological Barriers Limit Human Progression in Ten Sport Monuments (2008) (40)
- Proapoptotic regimes for HTLV-I-transformed cells: targeting Tax and the NF-κB pathway (2005) (40)
- Homing Receptor α4β7 Integrin Expression Predicts Digestive Tract Involvement in Mantle Cell Lymphoma (1998) (39)
- Induction of autophagy and autophagy‐dependent apoptosis in diffuse large B‐cell lymphoma by a new antimalarial artemisinin derivative, SM1044 (2017) (39)
- Controversies in Targeted Therapy of Adult T Cell Leukemia/Lymphoma: ON Target or OFF Target Effects? (2011) (39)
- Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal (2021) (39)
- The combination of arsenic, interferon-alpha, and zidovudine restores an “immunocompetent-like” cytokine expression profile in patients with adult T-cell leukemia lymphoma (2013) (39)
- Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort (2021) (39)
- Treatment of Older Patients With Mantle Cell Lymphoma (MCL): Long-Term Follow-Up of the Randomized European MCL Elderly Trial. (2019) (39)
- Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: A series of 26 cases and literature review. (2016) (39)
- Animal models on HTLV-1 and related viruses: what did we learn? (2012) (39)
- Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GN. (2016) (38)
- Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study. (2019) (38)
- Iron-Deficiency Anemia in Castleman Disease: Implication of the Interleukin 6/Hepcidin Pathway (2010) (38)
- EAPB0203, a member of the imidazoquinoxaline family, inhibits growth and induces caspase-dependent apoptosis in T-cell lymphomas and HTLV-I-associated adult T-cell leukemia/lymphoma. (2008) (38)
- Interest of interferon alpha in systemic mastocytosis. The French experience and review of the literature. (2004) (38)
- Hypereosinophilia as a presenting sign of acute graft-versus-host disease after allogeneic bone marrow transplantation (2002) (37)
- Abnormal properties of red blood cells suggest a role in the pathophysiology of Gaucher disease. (2013) (37)
- Lessons to Learn From Low-Dose Cyclosporin-A: A New Approach for Unexpected Clinical Applications (2019) (37)
- Extranodal natural killer/T-cell lymphoma: advances in the management (2011) (37)
- Lenalidomide as salvage treatment for multiple myeloma relapsing after allogeneic hematopoietic stem cell transplantation: a report from the French Society of Bone Marrow and Cellular Therapy (2013) (37)
- Pathophysiological aspects of memory B-cell development. (2008) (37)
- Rituximab Maintenance Versus Wait and Watch after Four Courses of R-DHAP Followed By Autologous Stem Cell transplantation in Previously Untreated Young Patients with Mantle Cell Lymphoma: First Interim Analysis of the Phase III Prospective Lyma Trial, a Lysa Study (2014) (37)
- Pre-transplant donor CD4− invariant NKT cell expansion capacity predicts the occurrence of acute graft-versus-host disease (2017) (37)
- Differential expression and function of IgA receptors (CD89 and CD71) during maturation of dendritic cells (2004) (37)
- Rapamycin for Refractory Acute Graft-Versus-Host Disease (2009) (37)
- The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies (2022) (37)
- Time to progression of mantle cell lymphoma after high‐dose cytarabine‐based regimens defines patients risk for death (2018) (37)
- Pulmonary toxicity of chemotherapy and G/GM-CSF: a report of five cases. (1999) (37)
- Lack of Efficacy of 2-Chlorodeoxyadenoside in the Treatment of Splenic Lymphoma with Villous Lymphocytes (2000) (36)
- Zidovudine and interferon-α treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran (2007) (36)
- Prevention of mantle lymphoma tumor establishment by routing transferrin receptor toward lysosomal compartments. (2007) (36)
- Nuclear-to-cytoplasmic Relocalization of the Proliferating Cell Nuclear Antigen (PCNA) during Differentiation Involves a Chromosome Region Maintenance 1 (CRM1)-dependent Export and Is a Prerequisite for PCNA Antiapoptotic Activity in Mature Neutrophils* (2012) (36)
- Favorable radiological outcome of skeletal Erdheim-Chester disease involvement with anakinra. (2012) (36)
- Retinoic acid for treatment of multicentric Castleman's disease (1999) (35)
- Mast cell sarcoma: a rare and aggressive entity--report of two cases and review of the literature. (2013) (35)
- Mastocytosis in adulthood and neuropsychiatric disorders. (2016) (34)
- R-CHOP/R-DHAP Compared to R-CHOP Induction Followed by High Dose Therapy with Autologous Stem Cell Transplantation Induces Higher Rates of Molecular Remission In MCL: Results of the MCL Younger Intergroup Trial of the European MCL Network (2010) (34)
- Deferasirox and Vitamin D Improves Overall Survival in Elderly Patients with Acute Myeloid Leukemia after Demethylating Agents Failure (2013) (34)
- A role for caspases in the differentiation of erythroid cells and macrophages. (2008) (34)
- Severe pulmonary arterial hypertension as initial manifestation of intravascular lymphoma: Case report (2005) (34)
- Enteropathy-Associated T-Cell Lymphoma: Improving Treatment Strategies (2015) (34)
- Autologous Stem Cell Transplantation (ASCT) Versus Oral Melphalan and High-Dose Dexamethasone in Patients with AL (Primary) Amyloidosis: Results of the French Multicentric Randomized Trial (MAG and IFM Intergroup). (2005) (34)
- Mast cell sarcoma: new cases and literature review (2016) (34)
- Serotonin Is a Key Factor for Mouse Red Blood Cell Survival (2013) (34)
- Tax Protein-induced Expression of Antiapoptotic Bfl-1 Protein Contributes to Survival of Human T-cell Leukemia Virus Type 1 (HTLV-1)-infected T-cells*♦ (2012) (34)
- Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis (2022) (33)
- Efficacy of Anakinra for Various Types of Crystal-Induced Arthritis in Complex Hospitalized Patients: A Case Series and Review of the Literature (2015) (33)
- Positive Correlation between Epstein-Barr Virus Viral Load and Anti-Viral Capsid Immunoglobulin G Titers Determined for Hodgkin's Lymphoma Patients and Their Relatives (2006) (33)
- Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 10th annual conference of the European Mantle Cell Lymphoma Network (2011) (33)
- Mast cells and inflammation. (2013) (33)
- Omalizumab Therapy for Mast Cell-Mediator Symptoms in Patients with ISM, CM, MMAS, and MCAS. (2019) (33)
- Using Rituximab Plus Fludarabine and Cyclophosphamide as a Treatment for Refractory Mixed Cryoglobulinemia Associated With Lymphoma (2013) (33)
- Inhibitory effect of semaphorin‐3A, a known axon guidance molecule, in the human thymocyte migration induced by CXCL12 (2012) (33)
- NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study (2018) (33)
- European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives (2012) (32)
- Outcomes of Gene Therapy for Severe Sickle Disease and Beta-Thalassemia Major Via Transplantation of Autologous Hematopoietic Stem Cells Transduced Ex Vivo with a Lentiviral Beta AT87Q-Globin Vector (2015) (32)
- A novel, highly potent and selective phosphodiesterase-9 inhibitor for the treatment of sickle cell disease (2019) (32)
- Response to 5‐azacytidine in a patient with TET2‐mutated angioimmunoblastic T‐cell lymphoma and chronic myelomonocytic leukaemia preceded by an EBV‐positive large B‐cell lymphoma (2017) (32)
- Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow-up Samples From Four Prospective Trials of the European MCL Network (2020) (32)
- Disruption of phactr-1 pathway triggers pro-inflammatory and pro-atherogenic factors: New insights in atherosclerosis development. (2015) (32)
- Adult T cell leukaemia: a review of established and new treatments. (1998) (32)
- Schwann cells orchestrate peripheral nerve inflammation through the expression of CSF1, IL‐34, and SCF in amyotrophic lateral sclerosis (2019) (32)
- EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19 (2021) (32)
- Comparison of lenograstim vs filgrastim administration following chemotherapy for peripheral blood stem cell (PBSC) collection: a retrospective study of 126 patients. (1999) (32)
- Fractionated Doses of Gemtuzumab Ozogamicin (GO) Combined to Standard Chemotherapy (CT) Improve Event-Free and Overall Survival in Newly-Diagnosed De Novo AML Patients Aged 50–70 Years Old: A Prospective Randomized Phase 3 Trial From the Acute Leukemia French Association (ALFA) (2011) (32)
- Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study (2016) (31)
- PS-341 or a combination of arsenic trioxide and interferon-α inhibit growth and induce caspase-dependent apoptosis in KSHV/HHV-8-infected primary effusion lymphoma cells (2007) (31)
- Severe anoxic hepatic necrosis in an HIV-1-hepatitis C virus-co-infected patient starting antiretroviral triple combination therapy. (1998) (31)
- Prolonged remission of HIV-associated multicentric Castelman's disease with an anti-CD20 monoclonal antibody as primary therapy. (2003) (31)
- Regional enteritis associated with enterovirus in a patient with X-linked agammaglobulinemia. (2000) (31)
- R-CHOP Versus R-FC Followed by Maintenance with Rituximab Versus Interferon-Alfa: Outcome of the First Randomized Trial for Elderly Patients with Mantle Cell Lymphoma (2011) (31)
- The orphan GPR50 receptor promotes constitutive TGFβ receptor signaling and protects against cancer development (2018) (31)
- Treatment of Adult T-cell Leukemia-Lymphoma by CHOP Followed by Therapy with Antinucleosides, Alpha Interferon and Oral Etoposide (2002) (30)
- Acquired sideroblastic anaemia during treatment of Wilson's disease with triethylene tetramine dihydrochloride (1993) (30)
- A cytometric study of the red blood cells in Gaucher disease reveals their abnormal shape that may be involved in increased erythrophagocytosis (2011) (30)
- all‐trans‐retinoic acid in the treatment of Kimura's disease (2002) (30)
- The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives. (2019) (30)
- Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC (2016) (30)
- Masitinib as a chemosensitizer of canine tumor cell lines: a proof of concept study. (2012) (30)
- Neuropilins, Semaphorins, and Their Role in Thymocyte Development (2009) (30)
- Masitinib demonstrates anti-proliferative and pro-apoptotic activity in primary and metastatic feline injection-site sarcoma cells. (2012) (30)
- Peripheral blood 8 colour flow cytometry monitoring of hairy cell leukaemia allows detection of high‐risk patients (2014) (30)
- Adult T Cell Leukaemia (1998) (29)
- Is pegfilgrastim safe and effective in congenital neutropenia? An analysis of the French Severe Chronic Neutropenia registry (2009) (29)
- Blood CD34-c-Kit+ cell rate correlates with aggressive forms of systemic mastocytosis and behaves like a mast cell precursor. (2011) (29)
- TGF-beta1 drives and accelerates erythroid differentiation in the epo-dependent UT-7 cell line even in the absence of erythropoietin. (2000) (29)
- Regulation of globin-heme balance in Diamond-Blackfan anemia by HSP70/GATA1. (2019) (29)
- NRPa-308, a new neuropilin-1 antagonist, exerts in vitro anti-angiogenic and anti-proliferative effects and in vivo anti-cancer effects in a mouse xenograft model. (2018) (29)
- Treatment with Hypomethylating Agent 5-Azacytidine Induces Sustained Response in Angioimmunoblastic T Cell Lymphomas (2016) (29)
- Caspase-activated ROCK-1 allows erythroblast terminal maturation independently of cytokine-induced Rho signaling (2010) (29)
- Clinical, Metabolic and Molecular Responses After 4 Courses of R-DHAP and After Autologous Stem Cell Transplantation for Untreated Mantle Cell Lymphoma Patients Included in the LyMa Trial, a Lysa Study (2012) (29)
- Randomized Phase II Study of Clofarabine-Based Consolidation for Younger Adults With Acute Myeloid Leukemia in First Remission. (2017) (29)
- Macrophage, mast cell and T lymphocyte infiltrations are independent predictive biomarkers of primary refractoriness or early relapse in classical Hodgkin lymphoma (2013) (28)
- The role of 5‐HT2B receptors in mitral valvulopathy: bone marrow mobilization of endothelial progenitors (2017) (28)
- N-(4-hydroxyphenyl)retinamide induces growth arrest and apoptosis in HTLV-I-transformed cells (2004) (28)
- RCHOP and RDHAP Followed by Autologous Stem Cell Transplantation (ASCT) in Mantle Cell Lymphoma (MCL) : Final Results of a Phase II Study from the GELA (2008) (28)
- Modulation of histidine decarboxylase activity and cytokine synthesis in human leukemic cell lines: relationship with basophilic and/or megakaryocytic differentiation. (1999) (28)
- Triggering the TCR Developmental Checkpoint Activates a Therapeutically Targetable Tumor Suppressive Pathway in T-cell Leukemia. (2016) (28)
- p53 activation during ribosome biogenesis regulates normal erythroid differentiation. (2020) (28)
- Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up (2020) (28)
- Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial (2021) (28)
- Clinical Signs and Blood Test Results Among Humans Infected With Zoonotic Simian Foamy Virus: A Case-Control Study (2018) (27)
- Regulatory T-cell depletion in angioimmunoblastic T-cell lymphoma. (2010) (27)
- Enteropathy-associated T-cell lymphoma complicating an autoimmune enteropathy. (2012) (27)
- Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification (2020) (27)
- Le syndrome d’activation lymphohistiocytaire de l’adulte (2013) (27)
- A toxic palmitoylation of Cdc42 enhances NF-κB signaling and drives a severe autoinflammatory syndrome. (2020) (27)
- Intravenous Immunoglobulin Therapy for Pure Red Cell Aplasia Related to Human Parvovirus B 19 Infection : A Retrospective Study of 10 Patients and Review of the Literature (2013) (27)
- Cutaneous findings in sporadic and familial autosomal dominant hyper-IgE syndrome: a retrospective, single-center study of 21 patients diagnosed using molecular analysis. (2011) (27)
- BRAF(V600E) mutation in a histiocytic sarcoma arising from hairy cell leukemia. (2014) (27)
- Cytoplasmic proliferating cell nuclear antigen connects glycolysis and cell survival in acute myeloid leukemia (2016) (27)
- Midostaurin (PKC412) Demonstrates a High Rate of Durable Responses in Patients with Advanced Systemic Mastocytosis: Results from the Fully Accrued Global Phase 2 CPKC412D2201 Trial (2014) (27)
- Retinoic acid dramatically enhances the arsenic trioxide-induced cell cycle arrest and apoptosis in retinoic acid receptor alpha-positive human T-cell lymphotropic virus type-I-transformed cells. (2001) (27)
- Amelioration of differentiation of dendritic cells from CVID patients by intravenous immunoglobulin. (2005) (26)
- Rapid clearance of storage-induced micro-erythrocytes alters transfusion recovery. (2021) (26)
- Typical essential thrombocythaemia does not express bcr–abelson fusion transcript (2002) (26)
- Success in Developing Regions: World Records Evolution through a Geopolitical Prism (2009) (26)
- Further study of internal autocrine regulation of multipotent hematopoietic cells. (1993) (26)
- [Mastocytosis and anaesthesia]. (2009) (26)
- Systemic vasculitis and myelodysplastic syndromes. A report of two cases. (1997) (26)
- The severe phenotype of Diamond-Blackfan anemia is modulated by heat shock protein 70. (2017) (26)
- Erdheim-Chester Disease: a Concise Review (2019) (26)
- Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project (2020) (26)
- COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM) (2021) (26)
- Prevalence and risk factors for fragility fracture in systemic mastocytosis. (2017) (25)
- Hepatitis C Virus Infection and Lymphoma (2010) (25)
- Inhibition of mammalian target of rapamycin signaling by everolimus induces senescence in adult T‐cell leukemia/lymphoma and apoptosis in peripheral T‐cell lymphomas (2011) (25)
- Hepatitis E virus-induced primary cutaneous CD30(+) T cell lymphoproliferative disorder. (2017) (25)
- Targeted Treatment Options in Mastocytosis (2017) (25)
- Telangiectasia macularis eruptiva perstans (TMEP): A form of cutaneous mastocytosis with potential systemic involvement. (2016) (25)
- The VAD chemotherapy regimen plus a G-CSF dose of 10 μg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 μg/kg for progenitor cell mobilization: results from a monocentric study of 82 patients (2006) (25)
- Neuroprotective effect of masitinib in rats with postischemic stroke (2014) (25)
- Leukocyte telomere length in mastocytosis: Correlations with depression and perceived stress (2014) (25)
- Efficacy and safety of thalidomide in patients with inflammatory manifestations of chronic granulomatous disease: a retrospective case series. (2013) (25)
- Clinical and biological features of t(4;14) multiple myeloma: a prospective study (2011) (24)
- Oncogenetic landscape of lymphomagenesis in coeliac disease (2020) (24)
- Aggressive acute CD3+, CD56- T cell large granular lymphocyte leukemia with two stages of maturation arrest. (1996) (24)
- Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis. (2020) (24)
- Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial (2021) (24)
- Synthesis and structure-activity relationship of non-peptidic antagonists of neuropilin-1 receptor. (2014) (24)
- Antiapoptotic effect of ectopic TAL1/SCL expression in a human leukemic T-cell line. (1998) (24)
- Combination of intravenous immunoglobulins and lenalidomide in the treatment of scleromyxedema. (2013) (24)
- Identification of prognostic factors in post-transplant lymphoproliferative disorders. (2002) (24)
- Is There Still a Place for Total Body Irradiation (TBI) In the Conditioning Regimen of Autologous Stem Cell Transplantation In Mantle Cell Lymphoma ?: a Retrospective Study From the Lymphoma Working Party of the EBMT (2010) (23)
- MRD Eradication Should be the Therapeutic Goal in Mantle Cell Lymphoma and May Enable Tailored Treatment Approaches: Results of the Intergroup Trials of the European MCL Network (2014) (23)
- Novel Treatments of Adult T Cell Leukemia Lymphoma (2020) (23)
- Overview of Targeted Therapies for Adult T-Cell Leukemia/Lymphoma. (2017) (23)
- Serotonin, hematopoiesis and stem cells (2019) (23)
- KIT Inhibitor Midostaurin in Patients with Advanced Systemic Mastocytosis: Results of a Planned Interim Analysis of the Global CPKC412D2201 Trial (2012) (23)
- Oligoclonal proliferation of human T‐cell leukaemia virus type 1 bearing T cells in adult T‐cell leukaemia/lymphoma without deletion of the 3′ provirus integration sites (1998) (23)
- Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions (2020) (22)
- Long Term Efficacy and Safety of Cladribine In Adult Systemic mastocytosis: a French Multicenter Study of 44 Patients (2010) (22)
- Diagnosis of autoimmune lymphoproliferative syndrome caused by FAS deficiency in adults (2013) (22)
- Disseminated toxoplasmosis in non-allografted patients with hematologic malignancies: report of two cases and literature review (2013) (22)
- CHOP and DHAP plus rituximab followed by autologous stem cell transplantation (ASCT) in mantle cell lymphoma (MCL): A pilot study from the GELA. (2004) (22)
- Quantification of HTLV-1 reverse transcriptase activity in ATL patients treated with zidovudine and interferon-α. (2017) (22)
- In vivo and in vitro treatment of HTLV-1 and HTLV-2 infected cells with arsenic trioxide and interferon-a (2005) (22)
- Vitamin D Receptor Controls Cell Stemness in Acute Myeloid Leukemia and in Normal Bone Marrow. (2020) (22)
- Actualités sur la compréhension et le traitement des mastocytoses systémiques (2008) (22)
- Northern African strains of human T-lymphotropic virus type 1 arose from a recombination event (2014) (22)
- Efficacy of Ruxolitinib Therapy in a Patient With Severe Enterocolitis Associated With a STAT3 Gain-of-Function Mutation (2019) (21)
- Deaths associated with acquired haemophilia in France from 2000 to 2009: multiple cause analysis for best care strategies (2012) (21)
- Eighty percent of French sport winners in Olympic, World and Europeans competitions have mutations in the hemochromatosis HFE gene. (2015) (21)
- Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection (2019) (21)
- Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry (2019) (21)
- CD1d-restricted peripheral T cell lymphoma in mice and humans (2016) (21)
- Update on the molecular pathogenesis and clinical treatment of Mantle Cell Lymphoma (MCL): minutes of the 9th European MCL Network conference (2010) (20)
- Diagnostic Approaches and Established Treatments for Adult T Cell Leukemia Lymphoma (2020) (20)
- Neuropilin-1 Expression Characterizes T Follicular Helper (Tfh) Cells Activated during B Cell Differentiation in Human Secondary Lymphoid Organs (2013) (20)
- Serum Iron Protects from Renal Postischemic Injury. (2017) (20)
- Monitoring molecular response in adult T-cell leukemia by high-throughput sequencing analysis of HTLV-1 clonality (2017) (20)
- A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer. (2015) (20)
- Proposed Terminology and Classification of Pre-Malignant Neoplastic Conditions: A Consensus Proposal☆ (2017) (20)
- Clinical Trials of Adult T-Cell Leukaemia/Lymphoma Treatment (2012) (20)
- Pharmacokinetics of masitinib in cats (2009) (20)
- Carpal tunnel syndrome due to T cell lymphoma. (1995) (20)
- Erythropoiesis and transferrin receptors (2015) (20)
- FDG-PET/CT findings in systemic mastocytosis: a French multicentre study (2015) (20)
- Neuroimaging evidence of brain abnormalities in mastocytosis (2017) (20)
- 2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19 (2021) (20)
- EKLF-driven PIT1 expression is critical for mouse erythroid maturation in vivo and in vitro. (2013) (20)
- Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendations (2018) (19)
- Strong correlations of anti-viral capsid antigen antibody levels in first-degree relatives from families with Epstein-Barr virus-related lymphomas. (2009) (19)
- Clinical, Functional and Genetic Analysis of Twenty-Four Patients with Chronic Granulomatous Disease – Identification of Eight Novel Mutations in CYBB and NCF2 Genes (2012) (19)
- Plasma cell-directed therapies in monoclonal gammopathy-associated scleromyxedema. (2020) (19)
- Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network (2018) (19)
- Progressive Multifocal Leukoencephalopathy in Primary Immunodeficiencies (2018) (19)
- A French National Survey on Clotting Disorders in Mastocytosis (2015) (19)
- Inhibition of the erythropoietin-induced erythroid differentiation by granulocyte-macrophage colony-stimulating factor in the human UT-7 cell line is not due to a negative regulation of the erythropoietin receptor. (1996) (19)
- Predictors of early relapse in patients with non-infectious mixed cryoglobulinemia vasculitis: results from the French nationwide CryoVas survey. (2014) (19)
- Hepatitis C virus infection and MALT-type ocular adnexal lymphoma. (2006) (19)
- Gastrointestinal Behcet’s-like disease with myelodysplastic neoplasms with trisomy 8: a French case series and literature review (2018) (18)
- High-dose therapy with BEAC conditioning compared to BEAM conditioning prior to autologous stem cell transplantation for non-Hodgkin lymphoma: no differences in toxicity or outcome. A matched-control study of the EBMT-Lymphoma Working Party (2018) (18)
- Activin Receptor II Ligand Traps and Their Therapeutic Potential in Myelodysplastic Syndromes with Ring Sideroblasts (2016) (18)
- Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal. (2014) (18)
- Severe cardiac toxicity after monoclonal antibody therapy (2002) (18)
- Targeting acute myeloid leukemia dependency on VCP-mediated DNA repair through a selective second-generation small-molecule inhibitor (2021) (18)
- Inflammatory disorders associated with trisomy 8‐myelodysplastic syndromes: French retrospective case‐control study (2018) (18)
- Paediatric mastocytosis: long‐term follow‐up of 53 patients with whole sequencing of KIT. A prospective study (2018) (18)
- Atypical splice site mutations causing VEXAS syndrome. (2021) (18)
- Late-onset post-transplantation lymphoproliferative disorders after kidney transplantation: a monocentric study over three decades. (2013) (18)
- Mast Cell Leukaemia: c-KIT Mutations Are Not Always Positive (2012) (17)
- Coexistence and Parallel Evolution of Hypereosinophilic Syndrome, Autoimmune Hepatitis, and Ulcerative Colitis Suggest Common Pathogenic Features (2007) (17)
- Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma (2014) (17)
- The Believe Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept in Adult Beta-Thalassemia Patients Who Require Regular Red Blood Cell (RBC) Transfusions (2018) (17)
- Fludarabine therapy in patients with splenic lymphoma with villous lymphocytes: an update (2004) (17)
- IL‐3–producing basophils are required to exacerbate airway hyperresponsiveness in a murine inflammatory model (2018) (17)
- Treatment and prognosis of post-transplant lymphoproliferative disease. (1997) (17)
- In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas (2016) (17)
- PCIP-seq: simultaneous sequencing of integrated viral genomes and their insertion sites with long reads (2021) (17)
- The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies (2022) (17)
- Oral tyrosine kinase inhibitor masitinib in combination with gemcitabine in patients with advanced pancreatic cancer: A multicenter phase II study. (2016) (17)
- Treatment of younger patients with mantle cell lymphoma. (2011) (17)
- In vivo and in vitro treatment of HTLV-1 and HTLV-2 infected cells with arsenic trioxide and interferon-alpha. (2005) (17)
- Novel players in &bgr;-thalassemia dyserythropoiesis and new therapeutic strategies (2016) (17)
- Large granular lymphocytic leukemia: a treatable form of refractory celiac disease. (2012) (17)
- Genomic Profiling for Clinical Decision Making in Lymphoid Neoplasms. (2022) (17)
- Targeted deep sequencing reveals clonal and subclonal mutational signatures in Adult T-cell leukemia/lymphoma and defines an unfavorable indolent subtype (2020) (17)
- Iatrogenic Cushing's Syndrome Induced by Posaconazole (2013) (17)
- Human CD4- invariant NKT lymphocytes regulate graft versus host disease (2018) (16)
- Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials (2016) (16)
- Ocular adnexal lymphoma and Helicobacter pylori gastric infection (2010) (16)
- Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review. (2021) (16)
- Rituximab Maintenance after First-Line Immunochemotherapy in Mantle Cell Lymphoma: Long-Term Follow-up of the Randomized European MCL Elderly Trial (2017) (16)
- Masitinib decreases signs of canine atopic dermatitis: a multicentre, randomized, double-blind, placebo-controlled phase 3 trial. (2011) (16)
- Preliminary efficacy and safety results of masitinib administered, front line in patients with advanced GIST. A phase II study (2007) (16)
- Effect of interleukin-6 receptor antagonists in critically ill adult patients with COVID-19 pneumonia: two randomised controlled trials of the CORIMUNO-19 Collaborative Group (2022) (16)
- Physical health conditions and quality of life in adults with primary immunodeficiency diagnosed during childhood: A French Reference Center for PIDs (CEREDIH) study (2017) (16)
- Co‐regulation of heme oxygenase and erythropoietin genes (1991) (16)
- Innate immune cells, major protagonists of sickle cell disease pathophysiology (2020) (16)
- Hepatitis C virus - Associated marginal zone lymphoma. (2017) (16)
- Autologous stem cell transplantation in mantle cell lymphoma: a report from the SFGM-TC (2014) (16)
- Combined Linkage and Association Studies Show that HLA Class II Variants Control Levels of Antibodies against Epstein-Barr Virus Antigens (2014) (15)
- Enhanced Renewal of Erythroid Progenitors in Myelodysplastic Anemia by Peripheral Serotonin. (2019) (15)
- Prognostic Factors and Long Term Outcome of 138 Adults with Systemic Anaplastic Large-Cell Lymphoma: a Retrospective Study by the Groupe d'Etude Des Lymphomes De l'Adulte (GELA) (2010) (15)
- Cutaneous Richter’s Syndrome, Prognosis, and Clinical, Histological and Immunohistological Patterns: Report of Four Cases and Review of the Literature (2010) (15)
- Intravascular lymphoma associated with haemophagocytic syndrome: a very rare entity in western countries (2005) (15)
- Splenic lymphoma with villous lymphocytes, mixed cryoglobulinemia and HCV infection: deciphering the role of HCV in B-cell lymphomagenesis. (2007) (15)
- Defective palmitoylation of transferrin receptor triggers iron overload in Friedreich's ataxia fibroblasts. (2021) (15)
- HTLV-1-associated arthropathy treated with anti-TNF-alpha agent. (2014) (15)
- Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: A randomized controlled open-label trial. (2014) (15)
- Receptor kinase profiles identify a rationale for multitarget kinase inhibition in immature T-ALL (2013) (15)
- A Phase 2a, Open-Label, Dose-Finding Study To Determine The Safety and Tolerability Of Sotatercept (ACE-011) In Adults With Beta (β)-Thalassemia: Interim Results (2013) (15)
- Study Hgb-205: Outcomes of Gene Therapy for Hemoglobinopathies Via Transplantation of Autologous Hematopoietic Stem Cells Transduced Ex Vivo with a Lentiviral βΑ-T87Q-Globin Vector (LentiGlobin® BB305 Drug Product) (2014) (14)
- One hundred consecutive kidney transplantations with simultaneous ipsilateral nephrectomy in patients with autosomal dominant polycystic kidney disease (2013) (14)
- Ivory vertebra and systemic mastocytosis. (2012) (14)
- European mantle cell lymphoma network (2008) (14)
- Overall survival benefit with masitinib mesylate in imatinib-naive, locally advanced, or metastatic gastrointestinal stromal tumor (GIST): 4-years follow-up of the French Sarcoma Group phase II trial. (2011) (14)
- Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis (2021) (14)
- HTLV-1-associated inflammatory myopathies: low proviral load and moderate inflammation in 13 patients from West Indies and West Africa. (2013) (14)
- Thalidomide in advanced mastocytosis (2008) (14)
- Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis (2021) (14)
- Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registries (2018) (14)
- Profiling of circulating exosomal miRNAs in patients with Waldenström Macroglobulinemia (2018) (14)
- Comparative oncology: The paradigmatic example of canine and human mast cell neoplasms (2018) (14)
- Lack of the multidrug transporter MRP4/ABCC4 defines the PEL-negative blood group and impairs platelet aggregation. (2019) (14)
- High concentration of topical amitriptyline for treating chemotherapy-induced neuropathies (2019) (14)
- Case Report of Exposure to Voriconazole in the Second and Third Trimesters of Pregnancy (2012) (13)
- [COPD and erythropoiesis: interactions and consequences]. (2012) (13)
- HTLV‐1 positive and negative T cells cloned from infected individuals display telomerase and telomere genes deregulation that predominate in activated but untransformed CD4+ T cells (2012) (13)
- Quantitative RNA slot-blot analysis of CCND1/cyclin D1 expression in suspected mantle cell lymphoma (1998) (13)
- Recent advances in the understanding and therapeutic management of mastocytosis (2019) (13)
- Drug-induced minimal change nephropathy in a dog. (2010) (13)
- High‐dose CD34+ cells are not clinically relevant in reducing cytopenia and blood component consumption following myeloablative therapy and peripheral blood progenitor cell transplantation as compared with standard dose (2002) (13)
- Primary immunodeficiency-related bronchiectasis in adults: comparison with bronchiectasis of other etiologies in a French reference center (2019) (13)
- Adult T cell leukemia aggressivenness correlates with loss of both 5-hydroxymethylcytosine and TET2 expression. (2017) (13)
- Adult T-Cell Leukemia/Lymphoma in a Caucasian Patient After Sexual Transmission of Human T-Cell Lymphotropic Virus Type 1 (2015) (13)
- Severe prolonged red blood cell aplasia and thrombocytopenia induced by parvovirus B19 infection in a patient with sarcoidosis. (2003) (13)
- Long‐term efficacy and safety of 2CdA (cladribine) in extra‐pulmonary adult‐onset Langerhans cell histiocytosis: analysis of 23 cases from the French Histiocytosis Group and systematic literature review (2020) (13)
- Arsenic trioxide (As2O3) as a maintenance therapy for adult T cell leukemia/lymphoma (2020) (13)
- A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma (2022) (13)
- Uncomplicated neurosurgical resection of a malignant glioneuronal tumour under haemostatic cover of rFVIIa in a severe haemophilia patient with a high‐titre inhibitor: a case report and literature review of rFVIIa use in major surgeries (2010) (13)
- Depletion of CD11c+ cells in the CD11c.DTR model drives expansion of unique CD64+ Ly6C+ monocytes that are poised to release TNF-α (2015) (13)
- Most immature T-ALLs express Ra-IL3 (CD123): possible target for DT-IL3 therapy (2006) (13)
- Glomerular involvement in lymphoproliferative disorders with hyperproduction of cytokines (Castleman, POEMS). (2000) (13)
- Efficiency of hydroxychloroquine in the treatment of granulomatous complications in chronic granulomatous disease. (2008) (13)
- Mycosis fongoïde transformé chez un enfant : traitement par transplantation médullaire allogénique avec effet « graft-versus-lymphoma » (2007) (13)
- Arsenic trioxyde in the treatment of HTLV1 associated ATLL (2011) (12)
- Improving the diagnostic efficiency of primary immunodeficiencies with targeted next-generation sequencing. (2020) (12)
- Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma. (2022) (12)
- Masitinib in nonresectable pancreatic cancer: Results of a phase III randomized placebo-controlled trial. (2013) (12)
- Sustained complete cytologic and molecular remission induced by donor leucocyte infusions alone in an acute myeloblastic leukaemia in relapse after bone marrow transplantation (1996) (12)
- Semiquantitative analysis of residual disease in patients treated for adult T‐cell leukaemia/lymphoma (ATLL) (1999) (12)
- Fanconi syndrome in lymphoma patients: report of the first case series. (2010) (12)
- Enterobacter cloacae pyomyositis complicating chronic granulomatous disease and review of gram-negative bacilli pyomyositis (2013) (12)
- Effects of Chronic Masitinib Treatment in APPPS1dE9 Transgenic Mice Modeling Alzheimer's Disease. (2020) (12)
- Striving to cure adult T-cell leukaemia/lymphoma: a role for allogeneic stem cell transplant? (2016) (12)
- Differential expression of alpha- and beta-globin genes in erythroleukemic cell lines (1990) (12)
- Homing receptor alpha4beta7 integrin expression predicts digestive tract involvement in mantle cell lymphoma. (1998) (12)
- Confirmation of the Mantle Cell Lymphoma International Prognostic Index (MIPI) in An Independent Prospective Patient Cohort. (2009) (12)
- Durable Responses and Improved Quality Of Life With Midostaurin (PKC412) In Advanced Systemic Mastocytosis (SM): Updated Stage 1 Results Of The Global D2201 Trial (2013) (12)
- Traitement des mastocytoses systémiques (2003) (12)
- Hemophagocytic syndrome as a presenting sign of transformation of smoldering to acute adult T‐cell leukemia/lymphoma: Efficacy of anti‐retroviral and interferon therapy (2004) (12)
- Thalidomide as a Treatment for Refractory CGD Colitis (2009) (12)
- Feline low-grade intestinal T cell lymphoma: a unique natural model of human indolent T cell lymphoproliferative disorder of the gastrointestinal tract (2021) (12)
- Long-term survival analysis of masitinib in amyotrophic lateral sclerosis (2021) (12)
- Proposed Diagnostic Criteria and Classification of Canine Mast Cell Neoplasms: A Consensus Proposal (2021) (12)
- Decrease of cocaine, but not heroin, self-administration and relapse by the tyrosine kinase inhibitor masitinib in male Sprague Dawley rats (2018) (12)
- Ocular adnexal lymphoma and Helicobacter pylori gastric infection (2010) (11)
- Treatment of the Hypereosinophilic Syndrome with Interferon- (1995) (11)
- European mantle cell lymphoma network: An update on current first line trials (2008) (11)
- [Cutaneous transformation of chronic lymphoid leukemia into immunoblastic lymphoma. Cutaneous manifestation of Richter syndrome]. (1995) (11)
- Fluorescence Exclusion: A Simple Method to Assess Projected Surface, Volume and Morphology of Red Blood Cells Stored in Blood Bank (2018) (11)
- Whole body clonality analysis in an aggressive STLV-1 associated leukemia (ATLL) reveals an unexpected clonal complexity. (2017) (11)
- A Worldwide Meta-Analysis on the Use of Zidovudine and Interferon-alpha for the Treatment of Adult T–Cell Leukemia/Lymphoma. (2007) (11)
- Masitinib for the treatment of canine atopic dermatitis: a pilot study (2009) (11)
- Étiologies et orientation diagnostique devant un flush (2014) (11)
- Harnessing regulatory T cells for transplant tolerance in the clinic through mTOR inhibition: myth or reality? (2011) (11)
- Association of mastocytosis with inflammatory joint diseases: a series of 31 patients. (2014) (11)
- The Genetic Architecture of Chronic Mountain Sickness in Peru (2019) (11)
- Monoclonal Gammopathies and the Kidney (2003) (11)
- Association of acute neutrophilic dermatosis and myelodysplastic syndrome with (6; 9) chromosome translocation: a case report and review of the literature (2000) (11)
- Characteristics of B-Cell Lymphomas in HIV/HCV-Coinfected Patients During the Combined Antiretroviral Therapy Era: An ANRS CO16 LYMPHOVIR Cohort Study (2013) (11)
- ATL treatment: is it time to change? (2015) (11)
- A Prospective Phase II Trial of An L-Asparaginase Containing Regimen in Patients with Refractory or Relapsing Extra Nodal NK/T-Cell Lymphoma (2008) (11)
- The equilibrative nucleoside transporter 1 (ENT1) is critical for nucleotide homeostasis and optimal erythropoiesis. (2021) (11)
- Disseminated Spiroplasma apis Infection in Patient with Agammaglobulinemia, France (2018) (11)
- A chromosome 14q11/TCR alpha/delta specific yeast artificial chromosome improves the detection rate and characterization of chromosome abnormalities in T-lymphoproliferative disorders. (1997) (10)
- Future Perspectives on Drug Targeting in Adult T Cell Leukemia-Lymphoma (2018) (10)
- Serum Gp96 is a chaperone of complement-C3 during graft-versus-host disease. (2017) (10)
- Inherited glycosylphosphatidylinositol defects cause the rare Emm-negative blood phenotype and developmental disorders. (2021) (10)
- Granulocyte colony stimulating factor-induced exacerbation of fungus-related immune restoration inflammatory syndrome: a case of chronic disseminated candidiasis exacerbation. (2010) (10)
- Increased microvessel density in involved organs from patients with HTLV-I associated adult T cell leukemia lymphoma (2008) (10)
- The HTLV-1 viral oncoproteins Tax and HBZ reprogram the cellular mRNA splicing landscape (2021) (10)
- Global Classification of Mast Cell Activation Disorders An ICD-10-CM-Adjusted Proposal of the ECNM-AIM Consortium. (2022) (10)
- A Prospective, Multicenter, Randomized Study of Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Investigator's Choice in the Treatment of Patients with Relapsed/Refractory Adult T-Cell Leukemia-Lymphoma: Overall Response Rate, Progression-Free Survival, and Overall Survival (2016) (10)
- CD34 Identifies a Subset of Proliferating Microglial Cells Associated with Degenerating Motor Neurons in ALS (2019) (10)
- A major turning point in NK/T-cell lymphoma? (2017) (10)
- Histopathologic, phenotypic, and molecular criteria to discriminate low‐grade intestinal T‐cell lymphoma in cats from lymphoplasmacytic enteritis (2021) (10)
- Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma (2020) (10)
- A prospective, multicenter, randomized study of anti-CCR4 monoclonal antibody mogamulizumab (moga) vs investigator's choice (IC) in the treatment of patients (pts) with relapsed/refractory (R/R) adult T-cell leukemia-lymphoma (ATL). (2016) (10)
- Creatine kinase pathway inhibition alters GSK3 and WNT signaling in EVI1-positive AML (2018) (10)
- Brief report FAS-L, IL-10, and double-negative CD4 (cid:1) CD8 (cid:1) TCR (cid:2) / (cid:3) (cid:4) T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function (2009) (10)
- Rituximab‐Bendamustine (R‐Benda) in MALT lymphoma complicating primary Sjögren syndrome (pSS) (2019) (10)
- Efficacy and Safety of Cladribine in Adult Systemic Mastocytosis : A French Multicenter Study of 33 Patients. (2004) (10)
- Anti–Interleukin-6 and Janus Kinase Inhibitors for Severe Neurologic Toxicity of Checkpoint Inhibitors (2021) (10)
- Protein-based therapeutic for anemia caused by dyserythropoiesis (2016) (10)
- Dynamic Interaction between STLV-1 Proviral Load and T-Cell Response during Chronic Infection and after Immunosuppression in Non-Human Primates (2009) (10)
- A Single-Tube, EuroClonality-Inspired, TRG Clonality Multiplex PCR Aids Management of Patients with Enteropathic Diseases, including from Formaldehyde-Fixed, Paraffin-Embedded Tissues. (2019) (10)
- Neuropilin-1 peptide-like ligands with proline mimetics, tested using the improved chemiluminescence affinity detection method. (2019) (10)
- The efficacy of combined therapy of arsenic trioxide and alpha interferon in human T-cell leukemia virus type-1-infected squirrel monkeys (Saimiri sciureus). (2006) (10)
- Topoisomerase 2β mutation impairs early B cell development. (2020) (9)
- European MCL network: An update on current first line trials (2007) (9)
- Unexpected macrophage-independent dyserythropoiesis in Gaucher disease (2016) (9)
- Rituximab plus CHOP (R-CHOP) in the treatment of elderly patients with diffuse large B-cell lymphoma. An update of the GELA study. (2001) (9)
- Standards and standardization in mastocytosis (2007) (9)
- Poor outcome and high prevalence of invasive fungal infections in patients with adult T-cell leukemia/lymphoma exposed to zidovudine and interferon alfa (2021) (9)
- INTERIM RESULTS FROM A PHASE 2A, OPEN-LABEL, DOSE-FINDING STUDY OF SOTATERCEPT (ACE-011) IN ADULT PATIENTS (PTS) WITH BETA-THALASSEMIA (2015) (9)
- Utilization of intravenous or subcutaneous immunoglobulins in secondary immune deficiency (ULTIMATE): A retrospective multicenter study. (2020) (9)
- Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle? (2019) (9)
- LACK OF ASSOCIATION BETWEEN HCV INFECTION AND HIV‐RELATED LYMPHOMA (1999) (9)
- Adult T cell leukemia aggressivenness correlates with loss of both 5-hydroxymethylcytosine and TET2 expression (2016) (9)
- INTERIM RESULTS FROM A PHASE 2A, OPEN-LABEL, DOSE-FINDING STUDY TO DETERMINE THE SAFETY, EFFICACY, AND TOLERABILITY OF SOTATERCEPT (ACE-011) IN ADULTS WITH BETA-THALASSEMIA (2014) (9)
- Masitinib as an add-on therapy to riluzole is safe and effective in the treatment of amyotrophic lateral sclerosis (ALS) (2017) (9)
- Diffuse large B-cell lymphoma in hyperimmunoglobulinemia E syndrome. (2007) (9)
- Haploidentical stem cell transplantation for patients with lymphoma: a position statement from the Lymphoma Working Party-European Society for Blood and Marrow Transplantation (2019) (9)
- XPO1 regulates erythroid differentiation and is a new target for the treatment of β-thalassemia. (2019) (9)
- A spontaneous remission of lymphoid blast crisis in chronic myelogenous leukaemia following blood transfusion and infection (1994) (9)
- Longitudinal Effect of Luspatercept Treatment on Iron Overload and Iron Chelation Therapy (ICT) in Adult Patients (Pts) with β-Thalassemia in the Believe Trial (2020) (9)
- Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group (2022) (9)
- The timing of granulocyte–colony‐stimulating factor administration after chemotherapy does not affect stem and progenitor cell apheresis yield: a retrospective study of 65 cases (1999) (9)
- Liquid chromatography-tandem mass spectrometry assay for therapeutic drug monitoring of the tyrosine kinase inhibitor, midostaurin, in plasma from patients with advanced systemic mastocytosis. (2014) (9)
- Relocalization of KIT D816V to cell surface after dasatinib treatment: potential clinical implications. (2013) (9)
- Dual cytoplasmic and nuclear localization of HTLV-1-encoded HBZ protein is a unique feature of adult T-cell leukemia (2021) (9)
- Efficacy and Safety of Thalidomide In Mantle Cell Lymphoma: Results of the French ATU Program. (2010) (9)
- Thalidomide in systemic mastocytosis: results from an open‐label, multicentre, phase II study (2013) (9)
- Bone marrow tryptase as a possible diagnostic criterion for adult systemic mastocytosis (2016) (9)
- A phase III study of ibrutinib in combination with bendamustine and rituximab (BR) in elderly patients with newly diagnosed mantle cell lymphoma (MCL). (2013) (9)
- Autologous stem-cell transplantation as consolidation therapy for diffuse large B-cell lymphoma patients with overexpression of bcl-2 protein. Results of the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trial LNH98-B2. (2008) (9)
- Loss of interleukin-10 activates innate immunity to eradicate adult T-cell leukemia-initiating cells (2021) (8)
- [Hemophagocytic syndrome]. (2002) (8)
- Faculty Opinions recommendation of Mast cells: a cellular link between autoantibodies and inflammatory arthritis. (2014) (8)
- Rapid and clinically significant response to masitinib in the treatment of mucosal primary esophageal melanoma with somatic KIT exon 11 mutation involving brain metastases: A case report. (2015) (8)
- The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial (2020) (8)
- Safety of prophylactic use of darbepoetin alfa in patients with diffuse large B-Cell lymphoma (DLBCL) treated with R-CHOP 14 or RCHOP21: Preliminary results of the LNH03-6B randomized GELA study. (2006) (8)
- New Peptides Structurally Related to VEGF-A165 Exon-7 and -8 Encoded Domains Antagonize Its Binding to NRP-1 and VEGF-R1 (2015) (8)
- Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group. (2020) (8)
- APN/CD13 is over‐expressed by Psoriatic fibroblasts and is modulated by CGRP and IL‐4 but not by retinoic acid treatment (2018) (8)
- Persistent COVID-19 in an immunocompromised host treated by SARS-CoV-2-specific monoclonal antibodies (2021) (8)
- Hydroxychloroquine as a novel therapeutic approach in mast cell activation diseases. (2018) (8)
- Changes in patients population and characteristics of hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma: an analysis of the Lymphoma Working Party of the EBMT (2020) (8)
- Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis (2022) (8)
- Arsenic trioxide rewires mantle cell lymphoma response to bortezomib (2015) (8)
- High Response Rate After 4 Courses of R-DHAP In Untreated Mantle Cell Lymphoma (MCL) Patients In the Ongoing Phase III Randomized GOELAMS and GELA LyMa Trial (2010) (8)
- HFE Gene Mutation Status Predicts Response to Gemtuzumab Ozogamicin in AML (2015) (8)
- Endogenous erythroid colony formation in patients with retinal vein occlusion. (2007) (8)
- Longer Term Follow-up on the First Patients with Severe Hemoglobinopathies Treated with Lentiglobin Gene Therapy (2017) (8)
- Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative Group. (2022) (8)
- Chronic lymphocytic leukaemia responsive to vitamin D administration (2012) (8)
- FGFR3 Tyrosine Kinase Inhibitor AB1010 as Treatment of t(4;14) Multiple Myeloma. (2007) (8)
- [Iron therapy: Indications, limitations and modality]. (2013) (8)
- Amylose cardiaque : à propos d’une série de 14 patients, description et facteurs pronostiques (2013) (8)
- Sustained Reductions in Red Blood Cell (RBC) Transfusion Burden and Events in β-Thalassemia with Luspatercept: Longitudinal Results of the Believe Trial (2020) (8)
- Thyroid gland plasmacytoma with a dramatic and persistent complete response under thalidomide and dexamethasone-associated treatment (2006) (8)
- [Transformed juvenile-onset mycosis fungoides: treatment by bone marrow transplantation with graft-versus-lymphoma effect]. (2007) (8)
- R-DHA-Oxaliplatin before Autologous Stem Cell Transplantation Prolongs PFS and OS As Compared to R-DHA-Carboplatin and R-DHA-Cisplatin in Patients with Mantle Cell Lymphoma, a Subgroup Analysis of the LyMa Trial (2017) (7)
- Health-Related Quality of Life Outcomes for Patients with Transfusion-Dependent Beta-Thalassemia Treated with Luspatercept in the Believe Trial (2020) (7)
- Masatinib mesylate in imatinib-naive locally advanced or metastatic gastrointestinal stromal tumor (GIST): Results of the French Sarcoma Group phase II trial. (2009) (7)
- Treatment of HTLV-1 associated adult T-cell leukemia lymphoma with a combination of Zidovudine and alpha interferon. Report of the French experience (1999) (7)
- ROGNOSTIC SIGNIFICANCE OF BCL2 EXPRESSION IN AGGRESSIVE NON-HODGKIN’S LYMPHOMA. GROUPE D’ ETADE DES LYMPHOMAS DE L’ADULTE GELA (1996) (7)
- Disseminated Nasal-type Natural Killer/T-cell Lymphoma in a Child: A Case Report (2009) (7)
- Tumor Cell Proliferation (Ki-67 Index) Overcomes Cytology and Growth Pattern As Prognostic Factor in Mantle-Cell Lymphoma – Results from Randomized Trials of the European MCL Network (2014) (7)
- Éthique et transfusion sanguine – Échos d’un séminaire –☆☆☆ (2014) (7)
- Autologous Stem Cell Transplantation (ASCT) Versus Oral Melphalan and High-Dose Dexamethasone In Patients with AL (Primary) Amyloidosis: Long Term Follow-up of the French Multicentric Randomized Trial (2010) (7)
- Array‐CGH predicts prognosis in plasma cell post‐transplantation lymphoproliferative disorders (2017) (7)
- Results from the Completed Hgb-205 Trial of Lentiglobin for β-Thalassemia and Lentiglobin for Sickle Cell Disease Gene Therapy (2019) (7)
- Helicobacter bilis-Associated Suppurative Cholangitis in a Patient with X-Linked Agammaglobulinemia (2017) (7)
- Pooled Survival Analysis Of Midostaurin Clinical Study Data (D2201+A2213) In Patients With Advanced Systemic Mastocytosis Compared With Historical Controls (2017) (7)
- Cell Proliferation (Ki-67) As Prognostic Marker in Mantle Cell Lymphoma. (2012) (7)
- Immune interventions in COVID-19: a matter of time? (2021) (7)
- Faculty Opinions recommendation of Cutting edge: mast cells critically augment myeloid-derived suppressor cell activity. (2014) (7)
- Addition of High-Dose Cytarabine to Immunochemotherapy before Autologous Stem-Cell Transplantation in Patients Aged 65 Years or Younger with Mantle Cell Lymphoma (MCL Younger): A Long-Term Follow-up of the Randomized, Open-Label, Phase 3 Trial of the European Mantle Cell Lymphoma Network (2021) (7)
- Early blood transcriptomic signature predicts patients' outcome after out-of-hospital cardiac arrest. (2019) (7)
- Efficacy of All-Trans-Retinoic Acid in High-Risk Acute Myeloid Leukemia with Overexpression of EVI1 (2019) (7)
- Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party (2020) (7)
- Salvage therapy of Autoimmune Thrombocytopenic Purpura revealing non‐Hodgkin Lymphoma by the thrombopoietin receptor agonist romiplostim (2012) (7)
- Human Muscle Progenitor Cells Displayed Immunosuppressive Effect through Galectin-1 and Semaphorin-3A (2012) (7)
- R-CHOP VERSUS R-FC FOLLOWED BY MAINTENANCE WITH RITUXIMAB OR IFN (2011) (7)
- Clinical Impact and Proposed Application of Molecular Markers, Genetic Variants and Cytogenetic Analysis in Mast Cell Neoplasms: Status 2022. (2022) (7)
- IL-6 levels are dramatically high in the sputum from children with sickle cell disease during acute chest syndrome. (2020) (7)
- TGF-β1 Prevents the Noncognate Maturation of Human Dendritic Langerhans Cells (1999) (7)
- Masitinib Significantly Decreases the Rate of Asthma Exacerbations in Patients with Severe Asthma Uncontrolled by Oral Corticosteroids: A Phase 3 Multicenter Study (2020) (6)
- Role Of High-Dose Cytarabine and Total Body Irradiation Conditioning before Autologous Stem Cell Transplantation In Mantle Cell Lymphoma - A Comparison Of Nordic MCL2, HOVON 45, and European MCL Younger Trials (2013) (6)
- Clofarabine-Based Consolidation Improves Relapse-Free Survival of Younger Adults with Non-Favorable Acute Myeloid Leukemia (AML) in First Remission: Results of the Randomized ALFA-0702/Clara Study (NCT 00932412) (2015) (6)
- Effects of butyrate on the erythropoietin receptor of cell line IW201 (1994) (6)
- Gain of affinity for VEGF165 binding within the VEGFR2/NRP1 cellular complex detected by an HTRF‐based binding assay (2018) (6)
- Does Cysteine Rule (CysR) Complete the CendR Principle? Increase in Affinity of Peptide Ligands for NRP-1 Through the Presence of N-Terminal Cysteine (2020) (6)
- Masitinib plus FOLFIRI for second line treatment of metastatic colorectal cancer: An open label phase Ib/II trial. (2015) (6)
- The NF-κB pathway is rarely spontaneously activated in mantle cell lymphoma (MCL) cell lines and patient's samples. (2014) (6)
- Adult T-Cell Leukemia: a Comprehensive Overview on Current and Promising Treatment Modalities (2021) (6)
- [Adult T-cell leukemia/lymphoma. Therapeutic aspects]. (2001) (6)
- Incidence and Prognosis of RTKs and RAS Mutations in CBF AML. A Retrospective Study of French Adult ALFA and Pediatric LAME Trials. (2004) (6)
- Recovery of acute renal failure and nephrotic syndrome following autologous stem cell transplantation for primary (AL) amyloidosis. (2003) (6)
- WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR 4 desensitization to CXCL 12 Short title : Impaired CXCR 4 desensitization in WHIM leukocytes (2004) (6)
- Immunological alterations and associated diseases in mandrills (Mandrillus sphinx) naturally co-infected with SIV and STLV. (2014) (6)
- Bilateral tumoral infiltration of the Achilles tendons revealing chronic myelomonocytic leukemia. (1993) (6)
- Urea moiety as amide bond mimetic in peptide-like inhibitors of VEGF-A165/NRP-1 complex. (2019) (6)
- Safety and efficacy of temsirolimus in combination with three different immuno-chemotherapy regimens in relapse and refractory mantle cell lymphoma, final results of the T3 phase IB trial of the LYSA (2020) (6)
- Metabolic rejuvenation upgrades circulatory functions of red blood cells stored under blood bank conditions (2020) (6)
- Predictive Power of FDG-PET Parameters at Diagnosis and after Induction in Patients with Mantle Cell Lymphoma, Interim Results from the LyMa-PET Project, Conducted on Behalf of the Lysa Group (2015) (6)
- Chronic Granulomatous Disease with the McLeod Phenotype: a French National Retrospective Case Series (2020) (6)
- Mastocytosis is not related to allergic diseases (2008) (6)
- [Erythropoiesis: a paradigm for the role of caspases in cell death and differentiation]. (2005) (6)
- Autoimmune Neutropenia After Kidney Transplantation: A Disregarded Entity of Posttransplant Neutropenia (2014) (6)
- Anti-Lymphoma Activity of Interferon-Free Antiviral Treatment in Patients with Indolent B-Cell Lymphomas Associated with Hepatitis C Virus Infection (2015) (6)
- Consensus conferences : guidelines on malignant lymphoma . part 2 : marginal zone lymphoma , mantle cell lymphoma , peripheral T-cell lymphoma (2013) (5)
- [HSP70, an erythropoiesis regulator that determines the fate of erythroblasts between death and differentiation]. (2013) (5)
- Chronic myelomonocytic leukemia as a cause of fatal uncontrolled inflammation in familial Mediterranean fever (2015) (5)
- Dissociation of humoral and cellular immune responses in kidney transplant recipients with EBV mucocutaneous ulcer (2020) (5)
- Effects of butyrate on the erythropoietin receptor of cell line IW201. (1994) (5)
- Innate-like T cells in children with sickle cell disease (2019) (5)
- Synthesis, 3D-structure and stability analyses of NRPa-308, a new promising anti-cancer agent. (2019) (5)
- Criteria for the regression of pediatric mastocytosis: a long-term follow-up. (2020) (5)
- Hepatitis C virus and lymphomagenesis: Another piece of evidence (2002) (5)
- Masitinib mesylate in imatinib-resistant advanced GIST: A randomized phase II trial. (2012) (5)
- Scoring the risk of having systemic mastocytosis in adult patients with mastocytosis in the skin. (2020) (5)
- Role of iconographic examinations in the treatment algorithm in Erdheim-Chester disease. (2011) (5)
- Effects of early high-dose erythropoietin on acute kidney injury following cardiac arrest: exploratory post hoc analyses from an open-label randomized trial (2019) (5)
- Haplotransplants Versus Other Alternative Donors for Allogeneic Stem Cell Transplantation in Non Hodgkin Lymphoma (NHL): A Retrospective Analysis of the EBMT Lymphoma Working Party (2014) (5)
- Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT (2020) (5)
- Emerging agents for the treatment of mantle cell lymphoma (2012) (5)
- Effects of Luspatercept on Iron Overload and Impact on Responders to Luspatercept: Results from the BELIEVE Trial (2019) (5)
- Aspergillus felis in Patient with Chronic Granulomatous Disease (2019) (5)
- Immunohistochemical staining for diagnosis of cutaneous mastocytosis (2017) (5)
- Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseases (2021) (5)
- Enteropathy-Associated T-Cell Lymphoma Type I, But Not Refractory Celiac Disease, Strongly Expresses CD30 and Might Benefit From Brentuximab Vedotin (2013) (5)
- Churg and Strauss vasculitis in the course of masitinib treatment: a first report (2009) (5)
- Precision Medicine in Hematology 2021: Definitions, Tools, Perspectives, and Open Questions (2021) (5)
- Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User´s Guide for Daily Clinical Practice. (2022) (5)
- Clinical Outcome of Mantle Cell Lymphoma Patients with High Risk Biology (high Ki-67, blastic MCL, or high p53 expression) (2019) (5)
- Les mastocytoses systémiques (2005) (5)
- Supplémentation en fer : indications, limites et modalités (2013) (5)
- Urea-Peptide Hybrids as VEGF-A165/NRP-1 Complex Inhibitors with Improved Receptor Affinity and Biological Properties (2020) (5)
- XPO1 (Exportin-1) Is a Major Regulator of Human Erythroid Differentiation. Potential Clinical Applications to Decrease Ineffective Erythropoiesis of Beta-Thalassemia (2015) (5)
- Treatment of the hypereosinophilic syndrome with interferon-alpha. (1995) (5)
- 279. Clinical Outcomes of Gene Therapy with BB305 Lentiviral Vector for Sickle Cell Disease and β-Thalassemia (2016) (5)
- XPO1 regulates erythroid differentiation and is a new target for the treatment of β-thalassemia (2019) (5)
- Update from the Hgb-205 Phase 1/2 Clinical Study of Lentiglobin Gene Therapy: Sustained Clinical Benefit in Severe Hemoglobinopathies (2016) (5)
- Masitinib plus gemcitabine as first-line treatment of pancreatic cancer with pain: Results from phase 3 study AB12005. (2021) (5)
- Iron-loaded transferrin potentiates erythropoietin effects on erythroblast proliferation and survival: A novel role through transferrin receptors. (2021) (5)
- Multiple recombinant events in human T-cell Leukemia virus Type 1: complete sequences of recombinant African strains (2020) (5)
- Protective Effect of Systemic Administration of Erythropoietin on Auditory Brain Stem Response and Compound Action Potential Thresholds in an Animal Model of Cochlear Implantation (2011) (5)
- Immune phenotyping of Erdheim-Chester disease through mass cytometry highlights decreased proportion of non-classical monocytes and increased proportion of Th17 cells (2020) (4)
- Safety and efficacy of brentuximab vedotin as a treatment for lymphoproliferative disorders in primary immunodeficiencies. (2019) (4)
- Treatment of Advanced Systemic Mastocytosis with PKC412: The French Compassionate Use Programme Experience and Historical Comparison (2014) (4)
- The dose of granulocyte–colony‐stimulating factor after chemopriming treatment does not influence apheresis yield of progenitor cells: a retrospective study of 91 cases (1999) (4)
- TCL1 expression patterns in Waldenström macroglobulinemia (2016) (4)
- Storage-Induced Micro-Erythrocytes Are Rapidly Cleared from Recipient Circulation and Predict Transfusion Recovery (2019) (4)
- Management of Mantle Cell Lymphoma in the Elderly: Current and Potential Strategies (2013) (4)
- The Eatl-001 Trial: Results of a Phase 2 Study of Brentuximab Vedotin and CHP Followed By Consolidation with High-Dose Therapy - Autologous Stem-Cell Transplantation (HDT-ASCT) in the Frontline Treatment of Patients with Enteropathy-Associated T-Cell Lymphoma (2021) (4)
- Lymphomes non hodgkiniens T et NK périphériques (2014) (4)
- [Adult T-cell leukemia/lymphoma. Clinical aspects]. (2001) (4)
- A neuropathological study of cerebrovascular abnormalities in a signal transducer and activator of transcription 3-deficient patient. (2015) (4)
- Some aspects of the regulation of erythropoietin gene expression. (1991) (4)
- Refined Treatment Response Criteria for Indolent Systemic Mastocytosis proposed by the ECNM-AIM Consortium. (2022) (4)
- Polymyositis associated with Ki-1 lymphoma. (1995) (4)
- CD30 expression in cutaneous lesions of systemic mastocytosis: clinical, biological and histopathological analysis of 27 patients (2019) (4)
- Stepwise GATA1 and SMC3 mutations alter megakaryocyte differentiation in a Down syndrome leukemia model (2022) (4)
- Treatment of profound anemia with erythropoietin and steroids in a patient with X‐linked chronic granulomatous disease associated with MacLeod erythrocyte phenotype (2007) (4)
- Hepatitis B virus-associated B-cell non-Hodgkin lymphoma in non-endemic areas in Western Europe: Clinical characteristics and prognosis. (2019) (4)
- Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group. (2022) (4)
- S270: LONGER-TERM ANALYSIS OF EFFICACY OF LUSPATERCEPT VERSUS PLACEBO IN PATIENTS WITH TRANSFUSION-DEPENDENT BETA-THALASSEMIA ENROLLED IN THE BELIEVE STUDY (2022) (4)
- Development of an anti-HTLV-1 vaccine for the treatment of Adult T-cell Leukemia/Lymphoma (2015) (4)
- [Hemophagocytic lymphohistiocytosis]. (2013) (4)
- Mast Cell Leukemia: Clinical and Molecular Features and Survival Outcomes of Patients in the ECNM Registry. (2022) (4)
- Late Breaking Abstract - Masitinib in severe asthma: Results from a randomized, phase 3 trial (2020) (4)
- LRPAP1-autoantibodies in mantle cell lymphoma are associated with superior outcome. (2021) (4)
- RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia (2022) (4)
- Biosimilar Compared With Originator Filgrastim For Related-Donor Allogeneic Stem Cell Mobilisation: A Prospective-Historical Control Study (2013) (4)
- [Cardiac amyloidosis: a case series of 14 patients, description and prognosis]. (2013) (4)
- P1518: LONG-TERM SAFETY RESULTS OF THE BELIEVE STUDY OF LUSPATERCEPT IN ADULTS WITH ΒETA-THALASSEMIA (2022) (4)
- HSP70 un régulateur de l’érythropoïèse qui détermine le destin des érythroblastes entre mort et différenciation (2013) (4)
- Proposed ECNM-AIM Response Criteria in Advanced Systemic Mastocytosis. (2022) (4)
- Glomérulonéphrite extra-membraneuse au cours d’un syndrome de Gougerot-Sjogren primitif (2005) (4)
- Current Spectrum of Infections in Patients with X-Linked Agammaglobulinemia (2021) (4)
- An Improved Sequencing-Based Bioinformatics Pipeline to Track the Distribution and Clonal Architecture of Proviral Integration Sites (2020) (4)
- Clinical, laboratory and ultrasonographic findings differentiating low‐grade intestinal T‐cell lymphoma from lymphoplasmacytic enteritis in cats (2021) (4)
- [Current concepts and treatment advances in systemic mastocytosis]. (2009) (4)
- Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 Years (2021) (4)
- Safety of Autologous Hematopoietic Stem Cell Transplantation with Gene Addition Therapy for Transfusion-Dependent β-Thalassemia, Sickle Cell Disease, and Cerebral Adrenoleukodystrophy (2020) (4)
- [A medical-pharmaceutical partnership model as a contributor to the success in conditioning regimen for allogenic hematopoietic stem cell transplantation in adults: a cross-reflection on our organizations]. (2012) (4)
- Mastocytosis among elderly patients (2016) (4)
- The pathogenic role of c-Kit+ mast cells in the spinal motor neuron-vascular niche in ALS (2021) (4)
- [Membranous glomerulonephritis during primary Gougerot-Sjögren syndrome]. (2005) (3)
- A Multicenter Phase I/II Dose Escalation Study of Lenalidomide in Combination with Melphalan and Dexamethasone in Subjects with Newly-Diagnosed Light-Chain (AL)-Amyloidosis. (2008) (3)
- First Line Antiviral Therapy Significantly Improves Survival of Patients with Acute, Chronic and Smoldering ATL: a Worldwide Meta-Analysis. (2009) (3)
- Evaluating Luspatercept Responders in the Phase 3, Randomized, Double-Blind, Placebo-Controlled BELIEVE Trial of Luspatercept in Adult Beta-Thalassemia Patients (Pts) Who Require Regular Red Blood Cell (RBC) Transfusions (2019) (3)
- Neurological Involvement in Childhood Evans Syndrome (2019) (3)
- Establishing diagnostic criteria for mastocytosis in skin biopsies (2021) (3)
- Risque élevé de dysfonction cardiaque des leucémies aiguës myéloïdes secondaires à un cancer du sein (2010) (3)
- Clinical potential of midostaurin in advanced systemic mastocytosis (2017) (3)
- HbS promotes TLR4-mediated monocyte activation and pro-inflammatory cytokine production in sickle cell disease. (2022) (3)
- Pooled CRISPR Inverse PCR sequencing (PCIP-seq): simultaneous sequencing of retroviral insertion points and the associated provirus in thousands of cells with long reads (2019) (3)
- Efficacy and safety of convalescent plasma to treat hospitalised COVID-19 patients with or without underlying immunodeficiency: a randomized clinical trial (2022) (3)
- Purpuras thrombotiques thrombocytopéniques, syndromes hémolytiques et urémiques, micro-angiopathies thrombotiques (1998) (3)
- Remission Status at Transplantation and Treatment History Determine the Survival Chances of Patients after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia Who Had Received Pre-Treatment with Idelalisib: A Report from the EBMT Chronic Malignancies Working Party (2017) (3)
- Clinical Results of the Drepaglobe Trial for Sickle Cell Disease Patients (2021) (3)
- Recent advances in the first-line treatment of mantle cell lymphoma (2020) (3)
- Effect of Luspatercept in β-Thalassemia Patients with β0/β0 Genotype: A Subgroup Analysis of the BELIEVE Study (2022) (3)
- Hsp70, l’ange gardien de GATA-1 lors de la différenciation des globules rouges (2008) (3)
- Higher prevalence of vertebral fractures in systemic mastocytosis, but not in cutaneous mastocytosis and idiopathic mast cell activation syndrome (2019) (3)
- Absence of circulating mast cell precursors in paediatric mastocytosis: could it reflect a different pathophysiology between adults and children with mastocytosis? (2014) (3)
- Bilateral MALT-type ocular adnexal lymphoma with marginal zone lymphoma leukaemic cells and ophthalmological diffuse large B cell lymphoma (2008) (3)
- Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma—Romanian Experience (2020) (3)
- Angiotensin-converting enzyme inhibitors for secondary erythrocytosis. (2004) (3)
- Isolated flushes without permanent, fixed or other skin lesions in patients with systemic mastocytosis: a case series of 9 patients (2015) (3)
- Remission of transformed myelodysplastic syndrome with fibrosis after danazol therapy (2002) (3)
- Growth factor‐associated graft‐versus‐host disease and mortality 10 years after allogeneic bone marrow transplantation (2012) (3)
- AMAHRELIS : ADCETRIS MAINTENANCE AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN HODGKIN LYMPHOMA : A REAL LIFE STUDY FROM SFGMTC AND LYSA GROUPS (2020) (3)
- Hematopoietic growth factors in drug-induced agranulocytosis. (1995) (3)
- Frequency of isolated cutaneous involvement in adult mastocytosis: a cohort study (2019) (3)
- Hsp70 Is a New Major Regulator of Erythropoiesis by Preventing Caspase-3-Mediated Cleavage of GATA-1. (2004) (3)
- Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS/AML patients (2022) (3)
- P53 BUT NOT SOX11 IHC HAS PROGNOSTIC VALUE INDEPENDENT OF MIPI AND KI‐67 IN PROSPECTIVE TRIALS OF THE EUROPEAN‐MCL NETWORK (2017) (3)
- Mobilized Multipotent Hematopoietic Progenitors Stabilize and Expand Regulatory T Cells to Protect Against Autoimmune Encephalomyelitis (2020) (3)
- Decreased tryptophan and increased kynurenine levels in mastocytosis associated with digestive symptoms (2016) (3)
- Clonal eosinophil and mast cell diseases: different in the same way? (2016) (3)
- Erythroferrone: the missing link in β-thalassemia? (2015) (3)
- Masitinib in imatinib-naive advanced gastrointestinal stromal tumor (GIST): Five-year follow-up of the French Sarcoma Group phase II trial. (2012) (3)
- [Efficiency and good tolerance of rituximab for idiopathic thrombocytopenic purpura revealing a 22q11 deletion syndrome]. (2016) (3)
- [Causes and differential diagnosis of flush]. (2014) (3)
- Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial (2021) (3)
- Impact of genotype in relapsed and refractory acute myeloid leukaemia patients treated with clofarabine and cytarabine: a retrospective study (2019) (3)
- UBA1 gene mutation in giant cell arteritis (2022) (3)
- Renal and adrenal gland localization of chronic myelomonocytic leukemia presenting as a kidney tumor. (1999) (3)
- Tocilizumab for severe acute chest syndrome in a child with sickle cell disease and dramatically high interleukin‐6 values in endotracheal and pleural fluids (2021) (3)
- Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (2023) (3)
- [High risk of cardiac dysfunction after treatment of secondary acute myeloid leukemia following chemotherapy and radiotherapy for breast cancer]. (2010) (3)
- The Quality of Anti-SARS-CoV-2 T Cell Responses Predicts the Neutralizing Antibody Titer in Convalescent Plasma Donors (2022) (3)
- Fas ligand-mediated lethal hepatitis after rapid lysis of a localized natural killer cell lymphoma. (2006) (3)
- [Hsp 70, guardian angel of GATA-1 during erythroid differentiation]. (2008) (2)
- Aspects moléculaires des lymphomes T périphériques (1) - Lymphome T angio-immunoblastique, lymphome T périphérique non spécifié et lymphome anaplasique à grandes cellules (2015) (2)
- A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial (2021) (2)
- Mast Cell Diseases in Practice and Research: Issues and Perspectives Raised by Patients and Their Recommendations to the Scientific Community and Beyond. (2022) (2)
- C-kit and Mastocytosis (2004) (2)
- The Spectrum Of Cold Agglutinin Disease At The Era Of Rituximab: A Retrospective Study On 48 Patients (2013) (2)
- Rituximab maintenance after autologous stem‐cell transplantation in patients with mantle cell lymphoma, final result of the LyMA trial conducted on behalf the LYSA group (2017) (2)
- [COVID-19: Still a place for tocilizumab?] (2020) (2)
- Les ROS : une nouvelle cible thérapeutique dans les leucémies ? (2010) (2)
- Biallelic mutations in the SARS2 gene presenting as congenital sideroblastic anemia (2021) (2)
- Modèle de coopération médico-pharmaceutique comme contributeur au succès du conditionnement de la greffe allogénique de cellules souches hématopoïétiques chez l’adulte : un regard croisé sur nos organisations (2012) (2)
- Télomères et télomérase: intérêts et perspectives dans le lupus érythémateux systémique (2010) (2)
- The feasibility of peripheral blood stem cell collection for autograft following failure in bone marrow aspiration. (1998) (2)
- Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma (2022) (2)
- Rationale and efficacy of CD52 targeting in HTLV-1-associated myositis. (2014) (2)
- Hairy-cell leukaemia in a renal transplant recipient. (1996) (2)
- Rituximab maintenance after combined immuno-chemotherapy significantly prolongs duration of remission in elderly patients with mantle cell lymphoma (2011) (2)
- Eight Colors Flow Cytometry Phenotyping for Blood Minimal Residual Disease Monitoring in Hairy Cell Leukaemia Patients. (2009) (2)
- A global phase II, single-arm, open-label study to determine the efficacy of midostaurin in patients with aggressive systemic mastocytosis (ASM) or mast cell leukemia (MCL) with or without an associated hematologic clonal nonmast cell lineage disease (AHNMD). (2011) (2)
- Safety and efficacy of brentuximab vedotin as a treatment for lymphoproliferative disorders in primary immunodeficiencies (2020) (2)
- Lack of Skeletal Muscle Serotonin Impairs Physical Performance (2021) (2)
- Identification of driver genes for severe forms of COVID-19 in a deeply phenotyped young patient cohort (2021) (2)
- Selection and Efficacy of Cytoreductive Agents in Patients with Mastocytosis Included in the Registry of the European Competence Network on Mastocytosis (ECNM) (2017) (2)
- Flt3 and MLL internal tandem duplications and topoisomerase II breakages reflect a common category of genotoxic stress: An EORTC study (2002) (2)
- Neuropilin-1 cooperates with PD-1 in CD8+ T cells predicting outcomes in melanoma patients treated with anti-PD1 (2022) (2)
- Splenic clearance of rigid erythrocytes as an inherited mechanism for splenomegaly and natural resistance to malaria (2022) (2)
- The real superdonors (2014) (2)
- Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis (2022) (2)
- Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group (2020) (2)
- Erythrocytosis associated with IgA nephropathy (2021) (2)
- MCL‐R2 ELDERLY: A PHASE III STUDY OF THE EUROPEAN MCL NETWORK ASSESSING EFFICACY OF ALTERNATING IMMUNOCHEMOTHERAPY (R‐CHOP / R‐HAD) AND a RITUXIMAB‐LENALIDOMIDE MAINTENANCE (2017) (2)
- Prognosis and outcome of stem cell transplantation for mantle cell lymphoma (2015) (2)
- Splenectomy for haemophagocytic lymphohistiocytosis of unknown origin: risks and benefits in 21 patients (2021) (2)
- The EBMT Lymphoma Working Party-European Mantle Cell Lymphoma Network Consensus Project On The Role Of Autologous and Allogeneic Stem Cell Transplantation In Mantle Cell Lymphoma: Recommendations Applying The Delphi Procedure (2013) (2)
- SUBSTITUTION OF OPIOIDS BY N-METHYL-D-ASPARTATE RECEPTOR ANTAGONISTS FOR TREATING PAIN IN MASTOCYTOSIS. (2020) (2)
- [Ethics and transfusion--seminar report]. (2014) (2)
- Outcome of COVID-19 in Patients With Mantle Cell Lymphoma—Report From the European MCL Registry (2022) (2)
- [Targeting oxidative metabolism to treat leukemia?]. (2010) (2)
- S103 OBINUTUZUMAB PLUS DHAP FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION PLUS OBINUTUZUMAB MAINTENANCE PROVIDES A HIGH MRD RESPONSE RATE IN UNTREATED MCL PATIENTS, LYMA-101 TRIAL - A LYSA TRIAL (2019) (2)
- Anorectal Epstein-Barr Virus Infection Mimicking Hodgkin Lymphoma in an Immunocompetent Man (2010) (2)
- Tocilizumab in Coronavirus Disease 2019: Give It Time! (2021) (2)
- High Prevalence of Hepatitis C Virus among B-Cell Non Hodgkin Lymphoma Patients in Mansoura Region (Egypt), ANRS 12263 Study (2019) (2)
- A New Digital Method for Counting Mast Cells in Cutaneous Specific Lesions of Mastocytosis: A Series of Adult Cases of Mastocytosis With Clinical-Pathological Correlations. (2020) (2)
- Masitinib plus irinotecan for second line treatment of esophagogastric adenocarcinoma: An open label phase Ib/II trial. (2015) (2)
- Prognostic Significance of Immunohistochemical Markers in Classical Hodgkin Lymphoma Response to Treatment A Study of 59 Cases. (2005) (2)
- Results from Treatment of a Large Cohort of ATL Patients from a Country with High HTLV1 Prevalence (2019) (2)
- Prise en charge des déficits immunitaires primitifs humoraux avec déficit en IgG et substitution par immunoglobulines humaines normales intraveineuses : résultats d’une enquête nationale (2010) (2)
- Tax as a therapeutic target in ATL (2015) (2)
- Recurrent TET2 mutations in adult T cell leukemia (2014) (2)
- Auto-Immune Origin of B Cells from HCV-Associated Lymphoma (2015) (2)
- [Thrombocytopenia after cardiac surgery due to anti-platelet allo-immunization. Apropos of a case]. (1997) (2)
- Rôle d’Hsp70 dans l’érythropoïèse inefficace des β-thalassémies majeures (2012) (2)
- COVID-19 : encore une place pour le tocilizumab ? (2020) (2)
- Besoins, prescriptions et sécurité des produits sanguins labiles ; autosuffisance en produits sanguins labiles (2014) (2)
- Impact of Donor-Derived Invariant Natural Killer T (iNKT) Cell Reconstitution After Allogeneic Haematopoietic Stem Cell Transplantation. (2009) (2)
- INDUCTION OF CELL CYCLE ARREST AND APOPTOSIS IN HTLV-I TRANSFORMED CELLS BY A COMBINATION OF ARSENIC TRIOXIDE AND INTERFERON-α (1999) (2)
- Abstract CT023: PATHFINDER: Interim analysis of avapritinib (ava) in patients (pts) with advanced systemic mastocytosis (AdvSM) (2021) (2)
- Molecular epidemiology of HTLV-1 infection in the caribbean area as compared to West Africa : relationship with the slave trade (2011) (2)
- Rituximab in Anti-Mag Associated Neuropathy : A Monocentric Experience. (2004) (2)
- Chronic lymphocytic lymphoma and multiple myeloma in a patient infected with human herpesvirus 8 (HHV‐8) (2002) (2)
- The combination of arsenic, interferon-alpha, and zidovudine restores an “immunocompetent-like” micro-environment in patients with adult T-cell leukemia lymphoma (2013) (2)
- Characteristics of SARS-CoV-2 infection in lymphoma/chronic lymphocytic leukemia patients during the Omicron outbreak (2022) (2)
- Immunohistochemical and virological features of HTLV-1-associated myosites: a study of 13 patients from West Indies and Africa (2011) (2)
- Traitement et pronostic des syndromes lymphoprolifératifs post-transplantation (1999) (2)
- The epigenetic regulator RINF (CXXC5) maintains SMAD7 expression in human immature erythroid cells and sustains red blood cells expansion. (2020) (2)
- A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency (2019) (2)
- Tocilizumab in COVID-19: Give it time! (2021) (2)
- NK/T‐CELL LYMPHOMA, THE FRENCH EXPERIENCE. (2017) (2)
- GlcNAc is a mast-cell chromatin-remodeling oncometabolite that promotes systemic mastocytosis aggressiveness. (2021) (2)
- A somatic mosaicism in the G6PD gene inducing a late onset chronic non‐spherocytic hemolytic anemia (2017) (2)
- Aspects moléculaires des lymphomes T périphériques (1) - Lymphome T angio-immunoblastique, lymphome T périphérique non spécifié et lymphome anaplasique à grandes cellules (2015) (2)
- Aspects moléculaires des lymphomes T périphériques (1) - Lymphome T angio-immunoblastique, lymphome T périphérique non spécifié et lymphome anaplasique à grandes cellules (2015) (2)
- [Molecular pathogenesis of peripheral T-cell lymphoma (1): angioimmunoblastic T-cell lymphoma, peripheral T-cell lymphoma, not otherwise specified and anaplastic large cell lymphoma]. (2015) (2)
- Anxiété et satisfaction des patients bénéficiant de la pose de chambre implantable pour une chimiothérapie anticancéreuse (2019) (1)
- PS1312 QPCR, MFC AND DDPCR: COMPARISON ON MRD SAMPLES FROM THREE PROSPECTIVE TRIALS OF THE EUROPEAN MCL NETWORK (2019) (1)
- Erratum to: Clinical, Functional and Genetic Analysis of Twenty-Four Patients with Chronic Granulomatous Disease—Identification of Eight Novel Mutations in CYBB and NCF2 Genes (2012) (1)
- Implications of deep molecular response after induction and in maintenance treatment in elderly patients with mantle cell lymphoma: updated results of the randomized EU-MCL elderly trial (2017) (1)
- Effective Anti–SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell Disorders (2022) (1)
- Adult T-cell leukemia/lymphoma in a Caucasian patient after sexual transmission of HTLV-1 (2015) (1)
- Outcome Of Patients With HTLV-1 Associated Adult T-Cell Leukemia/Lymphoma (ATL) Who Have Undergone Stem Cell Transplantation: A Retrospective Study Of The EBMT Lymphoma Working Party (2013) (1)
- S2043 Tumor Mass Reduction Surgery Improves the Prognosis of Enteropathy Associated T Cell Lymphoma (2010) (1)
- Hodgkin Variant of Richter's Syndrome: Report of 34 Cases. A Role of EBV in Transformation. (2009) (1)
- KIR3DL2 contributes to the typing of acute-type adult T-cell leukemia and is a potential therapeutic target. (2022) (1)
- Faculty Opinions recommendation of EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy. (2019) (1)
- Anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) or investigator’s choice of chemotherapy in subjects with relapsed or refractory adult T-cell leukemia-lymphoma (ATL). (2014) (1)
- The association of Greig syndrome and mastocytosis reveals the involvement of hedgehog pathway in advanced mastocytosis. (2021) (1)
- OBINUTUZUMAB PLUS DHAP FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) PLUS OBINUTUZUMAB MAINTENANCE PROVIDES A HIGH MRD RESPONSE RATE IN UNTREATED MCL PATIENTS. RESULTS OF LYMA‐101 TRIAL, A LYSA GROUP STUDY (2019) (1)
- Non-Canonical MYD88/TIRAP-Dependent Anti-Inflammatory Function of Pro-Coagulant Factor VIII (2019) (1)
- PCIP-seq: simultaneous sequencing of integrated viral genomes and their insertion sites with long reads (2021) (1)
- Monitoring Asparaginase Activity in 21 Patients with Extranodal NK/T-Cell Lymphoma Shows a Very High Proportion of Asparaginase Inactivation (2018) (1)
- Rituximab and High-Dose Cytarabine Do Not Counteract the Adverse Prognostic Value of CDKN2A and TP53 Deletions in Autografted Mantle-Cell Lymphoma Patients. a European-MCL Network Study (2014) (1)
- Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency (2022) (1)
- Curative allogeneic hematopoietic stem cell transplantation following reduced toxicity conditioning in adults with primary immunodeficiency (2022) (1)
- [HSP70 regulates ineffective erythropoiesis in beta-thalassaemia]. (2015) (1)
- Erythropoietin Downregulates Red Blood Cell Clearance in Mice (2019) (1)
- Use of Power Doppler Ultrasound in Haemophilia Could Predict Early Relapse of Intra Articular Bleeding after Haemarthrosis: A Prospective Cohort of 27 Haemarthrosis Monitored By Articular Ultrasound (2015) (1)
- Neuroprotective effect of masitinib in rats with postischemic stroke (2014) (1)
- Heat Shock Protein 70 over Expression Is Associated to Imatinib Resistance in Chronic Myelogenous Leukemia. (2005) (1)
- Iconographies supplémentaires de l'article : Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease (2014) (1)
- Histological Characteristics of Ataxia Telangiectasia Associated Lymphoproliferative Diseases. Results of the French Registry of Primary Immune Deficiencies (2014) (1)
- HTLV-1-infected HIS Rag2-/-γc-/- mice, a suitable model for in vivo investigating the effects of drugs in ATL treatment? (2011) (1)
- [Immunologic deficiencies. Optimizing diagnostic and therapeutic approaches]. (2007) (1)
- Early post-transplant donor-derived invariant natural killer T cell recovery predicts the occurrence of acute graft-versus-host disease and overall survival Running head : iNKT cells in human allogeneic (2012) (1)
- Modulation of Activin Signaling by RAP-011 (ActRIIA-IgG1) Improve Anemia, Increases Hemoglobin Levels and Corrects Ineffective Erythropoiesis in β-Thalassemia (2012) (1)
- Storage-Induced Micro-Erythrocytes Can Be Quantified and Sorted by Flow Cytometry (2022) (1)
- Tax unleashed: fulminant Tax-positive Adult T-cell Leukemia/Lymphoma after failed allogeneic stem cell transplantation. (2009) (1)
- How I treat How I treat adult T-cell leukemia/lymphoma (2011) (1)
- Allogeneic stem cell transplantation compared to conservative management in adults with inborn errors of immunity. (2022) (1)
- Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial (2023) (1)
- P1342Protective effect of masitinib on cardiovascular function of rats with pulmonary hypertension: gender dependence (2017) (1)
- SEMIQUANTITATIVE ANALYSIS OF RESIDUAL DISEASE IN PATIENTS TREATED FOR ADULT T-CELL LEUKEMIA/LYMPHOMA (ATLL) (1999) (1)
- Congenital Neutropenia Is Also Associated with a High Cancer Risk: A Study from the French Severe Chronic Neutropenia Registry (2020) (1)
- P16, c-Myc, SOX11, P53, ki67 and CD71Protein Expression in Aggressive Morphological Variants of Mantle Cell Lymphomas Compared to Classical Morphological Mantle Cell Lymphomas in Multiple Clinical Trials (2019) (1)
- BCL-2 Is Expressed in Advanced Mastocytosis and Midaustorin Induces Venetoclax Sensitivity of Mast Leukemia Cell Lines (2019) (1)
- BID Cleavage Pattern Is a Novel Check-Point That Determines the Fate of Human Erythroid Progenitors (Differentiation or Apoptosis (2016) (1)
- [Disseminated Propionibacterium acnes cutaneous infection in a neutropenic patient]. (1994) (1)
- SENSITIVITY ANALYSES FROM THE FIRST PHASE 3 CLINICAL STUDY OF MASITINIB (AB10015) IN ALS DEMONSTRATE ROBUSTNESS OF THE POSITIVE PRIMARY ANALYSIS (2018) (1)
- Frequent Alterations of Driver Genes in Chromosome X and Their Clinical Relevance in Extranodal NK/T-Cell Lymphoma (2022) (1)
- PREDICTION OF RELAPSE BY STANDARDIZED IG‐BASED ALLEL‐SPECIFIC QPCR, DDPCR AND AMPLICON NGS FOR MRD MONITORING IN MANTLE CELL LYMPHOMA: A COMPARATIVE ANALYSIS BY THE EU‐MCL NETWORK (2021) (1)
- Tax protein-induced expression of antiapoptotic Bfl-1 protein contributes to survival of human T-cell leukemia virus type 1 (HTLV-1)-infected T-cells. (2012) (1)
- [Patient support for primary immunodeficiency with hypogammaglobulinemia and intravenous immunoglobulin substitution: result of a national survey]. (2010) (1)
- Post-transplant lymphoproliferation disease : treatment and prognosis (1999) (1)
- Genetic Variants of TNFAIP3 in Patients with HCV Related Lymphoma Are Associated with the Presence of Rheumatoid Factor (RF) (2014) (1)
- New insights into HTLV entry (2011) (1)
- Leucemia a células T del adulto crónica: ¿Post-transmisión parenteral del Virus Linfotrópico T humano tipo 1 al nacer? (2016) (1)
- INFECTION CUTANEE DISSEMINEE A PROPIONIBACTERIUM ACNES CHEZ UN PATIENT NEUTROPENIQUE (1994) (1)
- Masitinib plus carboplatin and gemcitabine for treatment of patients with advanced triple negative breast cancer: An open label phase Ib/II trial. (2015) (1)
- Absence of severe COVID-19 in patients with clonal mast cells activation disorders: effective anti-SARS-CoV-2 immune response (2021) (1)
- Lack of the human choline transporter‐like protein SLC44A2 causes hearing impairment and a rare red blood phenotype (2023) (1)
- Functional common gamma chain is not required for mast cell proliferation and survival (2012) (1)
- Internal Autocrine Regulation of the Early Stages of Hemopoiesis a (1994) (1)
- Essential thrombocythaemia: a cause of Sneddon's syndrome (1996) (1)
- Mast cell density and its clinical relevance in Waldenström's macroglobulinemia (2017) (1)
- Adult T cell leukemia aggressivenness correlates with loss of both 5-hydroxymethylcytosine and TET 2 expression (2017) (1)
- [Molecular pathogenesis of peripheral T cell lymphoma (2): extranodal NK/T cell lymphoma, nasal type, adult T cell leukemia/lymphoma and enteropathy associated T cell lymphoma]. (2015) (1)
- Plasma histamine elevation in a large cohort of sickle cell disease patients (2019) (1)
- Hemin or butyrate increases constitutive erythropoietin formation by mouse erythroleukemia cell lines. (1993) (1)
- Human dendritic cells, which differentially trigger IgA complex endocytosis, up-regulate two IgA receptors (CD89 and CD71) during maturation (2004) (1)
- Neuroinflammatory disorders and mastocytosis: A possible association? (2019) (1)
- Faculty Opinions recommendation of Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observations. (2019) (1)
- PD‐1 BLOCKADE IN A FRENCH SERIES OF 13 RELAPSED / REFRACTORY NK/T‐CELL LYMPHOMA PATIENTS (2019) (1)
- Autologous stem cell transplantation in mantle cell lymphoma: a report from the SFGM-TC. (2014) (1)
- The EHA Research Roadmap: Normal Hematopoiesis (2021) (1)
- Co-Activation of AMPK and mTORC1 Is Synthetically Lethal in Acute Myeloid Leukemia (2014) (1)
- Tocilizumab in Treatment for Patients With COVID-19-Reply. (2021) (1)
- Role of Caspase-10-P13tBID axis in erythropoiesis regulation (2022) (1)
- Outcome after hematopoietic stem cell transplantation in patients with extranodal natural killer/T‐Cell lymphoma, nasal type: A French study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM‐TC) (2021) (1)
- A Syndrome of IgA-Related Polycythemia (2017) (1)
- Reply: COVID-19 drug research and the cohort multiple randomised controlled trial design (2022) (1)
- Red Blood Cell Adhesion to Vascular Endothelial Cells: A Culprit for Central Retinal Vein Occlusion (2010) (1)
- Adult T-Cell Leukaemia/Lymphoma (ATL) (2015) (1)
- Profiling of Circulating Exosomes in Patients with Waldenström Macroglobulinemia (2016) (1)
- Temsirolimus in Combination with Three Different Immuno-Chemotherapy Regimens in Relapse and Refractory Mantle Cell Lymphoma, Final Results of the T 3 Phase IB Trial of the Lysa Group (2016) (1)
- Image Gallery: The vulva: an atypical localization of mastocytosis in adulthood (2019) (1)
- Iron Parameters and Relation To Prognosis In Elderly Patients With Aggressive Lymphoma Receiving First Line Immunochemotherapy: An Analysis Of The Lysa LNH 03-6B Study (2013) (1)
- NKP46 EXPRESSION IS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER IN PRIMARY GASTROINTESTINAL T‐CELL LYMPHOPROLIFERATIONS. A CELAC NETWORK STUDY (2017) (1)
- Lymphome T et maladie cœliaque (1999) (1)
- Hematopoietic Stem-Cell Transplantation for Advanced SystemicMastocytosis (2014) (1)
- A toxic palmitoylation on Cdc42 drives a severe autoinflammatory syndrome (2019) (1)
- Common Variable Immunodeficiency Process Characterizes a Subset of Patients Impaired Antibody Affinity Maturation (2000) (1)
- High risk of cardiac dysfunction after treatment of secondary acute myeloid leukaemia to breast cancer. (2008) (1)
- Complete remission of a relapsing adult T cell leukaemia following treatment of a secondary acute promyelocytic leukaemia: towards a reappraisal of arsenic trioxide and all-transretinoic acid? (2009) (1)
- Title Pim kinases modulate resistance to FLT 3 tyrosine kinaseinhibitors in FLT 3-ITD acute myeloid leukemia (2015) (1)
- Malignancies and Outcome in Patients with Ataxia-Telangiectasia: Results From the French National Registry for Primary Immune Deficiencies. (2009) (1)
- Gene expression analysis in EBV-infected ataxia-telangiectasia cell lines by RNA-sequencing reveals protein synthesis defect and immune abnormalities (2021) (1)
- Effect of Luspatercept on Red Blood Cell (RBC) Transfusion Burden, Iron Chelation Therapy (ICT), and Iron Overload in Adults with Transfusion-Dependent β-Thalassemia (TDT) from the BELIEVE Trial: A Long-Term Analysis (2022) (1)
- Anticancer Activity of a Highly Potent Small Molecule Tubulin Polymerization Inhibitor, AB8939 (2019) (1)
- Autosuffisance, besoins, prescription et sécurité des produits sanguins labiles (2013) (1)
- Lymphomes T sous-cutanés de type panniculite : expérience clinique et anatomo-pathologique du Groupe français d’Étude des Lymphomes Cutanés (2013) (1)
- Idiopathic light‐chain proteinuria: Case report and review of the literature (2004) (1)
- L’érythropoïèse tardive : une mort avortée ? (2007) (1)
- Un nouveau mécanisme de l’anémie inflammatoire : la voie interleukine 6/hepcidine (2009) (1)
- Lymphomesnon hodgkinienset virus de l’hépatite C (2000) (1)
- Mastocytoses systémiques associées à un syndrome myélodysplasique (1996) (1)
- Pathologie lymphoïde maligne liée au virus HTLV-I : aspects physiopathologiques et orientations thérapeutiques nouvelles (1996) (1)
- Syndrome lymphoprolifératif auto-immun chez l’adulte : une cause rare mais sous-diagnostiquée de cytopénies auto-immunes (2010) (1)
- Iconography : Efficacité et bonne tolérance du rituximab sur un purpura thrombopénique immunologique chronique révélant un syndrome de délétion 22q11 (2016) (1)
- Les modifications hématologiques liées à la grossesse (1987) (1)
- Intérêt potentiel de l’érythropoïétine en post-arrêt cardiaque : présentation du protocole d’étude Epo-ACR 02 (2010) (1)
- P3-15 Faisabilité et risques de la collection de cellules souches périphériques parmi les patients atteints d'amylose AL (1998) (1)
- Tax as a therapeutic target in ATL (2015) (1)
- Gestion des effets secondaires des thérapies ciblées dans le cancer du rein : effets secondaires iatrogéniques (2011) (1)
- Clairance post-transfusionnelle des globules rouges stockés : analyse dans un modèle de rate humaine isolée-perfusée (2019) (1)
- Herpèsvirus humain 8 (HHV8) et pathologies lymphoïdes (1998) (1)
- Aspects moléculaires des lymphomes T périphériques (2) - Lymphome NK/T extra-ganglionnaire de type nasal, leucémie/lymphome T de l’adulte HTLV-1+, lymphome T associé à une entéropathie (2015) (1)
- Mastocytoses et anesthésie : conduite à tenir au cours de la période périopératoire (2017) (1)
- Glomérulonéphrite membrano-proliférative post-grippale chez un patient atteint de mastocytose systémique agressive : observation commentée et revue de la littérature (2021) (1)
- Cytopénies auto-immunes périphériques (2005) (1)
- Anomalies moléculaires au cours des mastocytoses : conséquences pronostiques et thérapeutiques (2014) (1)
- Les leucémies/lymphomes T de l’adulte liées au rétrovirus T-lymphotropique humain 1 (2018) (1)
- INTERFERON‐FREE ANTIVIRAL TREATMENT IN B‐CELL LYMPHOPROLIFERATIVE DISORDERS ASSOCIATED WITH CHRONIC HEPATITIS‐C VIRUS INFECTION (2017) (1)
- [Telomeres and telomerase: relevance and future prospects in systemic lupus erythematosus]. (2010) (1)
- S260: A MATCHED COMPARISON OF TISAGENLECLEUCEL AND AXICABTAGENE CILOLEUCEL CAR T CELLS IN RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A REAL-LIFE LYSA STUDY FROM THE FRENCH DESCAR-T REGISTRY (2022) (1)
- TAL1 activation in T-cell acute lymphoblastic leukemia: a novel oncogenic 3’ neo-enhancer (2023) (1)
- Anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) or investigator's choice in subjects with relapsed or refractory adult T-cell leukemia-lymphoma (ATL) (2015) (1)
- THE POTENTIAL PREVENTIVE AND CURATIVE EFFECTS OF MASITINIB IN THE APPPS1DE9 MOUSE MODEL OF ALZHEIMER'S DISEASE (2016) (0)
- Comment on Kieslinger et al. A Recurrent STAT5BN642H Driver Mutation in Feline Alimentary T Cell Lymphoma. Cancers 2021, 13, 5238 (2022) (0)
- 2145 Masitinib plus FOLFIRI for second-line treatment of metastatic colorectal cancer: 2-year follow-up of phase open label trial (2015) (0)
- Structuration nationale pour la prise en charge des lymphomes à petites (sprue réfractaire de type II) et grandes cellules associés à la maladie cœliaque (2008) (0)
- Shortened Firs t-Line High-Dose Chemotherapy for Pat ients With Poor-Prognosis Aggress ive Lymphoma (2002) (0)
- EFFICACY AND SAFETY OF RITUXIMAB IN B-CELL POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: RESULTS OF A PROSPECTIVE MULTICENTRE PHASE II STUDY Running head: Rituximab in PTLD (2017) (0)
- [Anemia and chemotherapy of malignant hemopathies]. (2003) (0)
- RED CELLS, IRON, AND ERYTHROPOIESIS EKLF-driven PIT1 expression is critical for mouse erythroid maturation in vivo and in vitro (2017) (0)
- Prevalence of Diagnosed Primary Immunodeficiencies Diseases in France: Results From the French National Registry and the CEREDIH Network. (2009) (0)
- Mastocytose systémique congénitale sévère associée à des mutations KIT et EZH2 (2020) (0)
- Une AREB bien tassée (2010) (0)
- Mantle Cell Lymphoma (2019) (0)
- Chronic diffuse mucocutaneous candidosis associated to IgG4 deficiency and tracheal neoplasia (1994) (0)
- megakaryocytes Platelet formation is the consequence of caspase activation within (2013) (0)
- T-cell lymphoma and celiac disease (1999) (0)
- Transplantation in adult T‐cell leukemia/lymphoma (2015) (0)
- [Systemic mastocytosis. Osteoporotic fracture as a manifestation]. (2011) (0)
- Enhancing Erythropoiesis by a Phytoestrogen Diarylheptanoid from Curcuma comosa (2022) (0)
- Clinico-Pathological Characteristics of B-Cell Non Hodgkins Lymphomas Associated with Hepatitis C Virus ANRS HC13 LYMPHO-C Observational Study. (2009) (0)
- Faculty Opinions recommendation of Mast cells play a protumorigenic role in primary cutaneous lymphoma. (2014) (0)
- Unique inflammatory signature in haemophilic arthropathy: miRNA changes due to interaction between blood and fibroblast‐like synoviocytes (2020) (0)
- Phenotypic and Genotypic Characteristics of Mastocytosis Differ According to the Age of Disease’s Onset. (2005) (0)
- [Management of side effects of targeted therapies in renal cancer: iatrogenic side effects]. (2011) (0)
- Brief report Blood CD34 (cid:1) c-Kit (cid:2) cell rate correlates with aggressive forms of systemic mastocytosis and behaves like a mast cell precursor (2011) (0)
- Regression of a CD30-Positive Primary Cutaneous T-Cell Lymphoproliferation after Ribavirin Treatment of Chronic Hepatitis E Virus Infection (2016) (0)
- P994: HEDGEHOG PATHWAY INVOLVEMENT IN MASTOCYTOSIS DEVELOPMENT (2022) (0)
- Caspase Activated Rock-1 Allows Erythroblasts Enucleation Independently of Cytokine Signaling (2008) (0)
- Deciphering the molecular basis of arsenic/interferon-alpha induced eradication of leukemia initiating cells in adult T cell leukemia (2015) (0)
- Mastocytose systémique. Y penser devant une ostéoporose fracturaire. (2011) (0)
- Abstract 5011: Potential tumor suppressor role of PHD2 : functional study of mutations identified in germline DNA of patients with congenital polycythemia with or without paraganglioma (2010) (0)
- Correlations between p16 Protein Expression and Genomic Profile in Mantle Cell Lymphoma and Impact on Survival, a Lyma-Genomic Project Conducted on Behalf of the Lysa Group (2018) (0)
- Caractéristiques en TEP au 18F-FDG des différentes formes de mastocytoses systémiques (2013) (0)
- Arthropathie associée à l’HTLV-1 traitée par anti-TNF alpha (2014) (0)
- BLNK mutation associated with T-cell LGL leukemia and autoimmune diseases: Case report in hematology (2022) (0)
- AB8939, a Microtubule-Destabilizing Agent with Potential to Overcome Multidrug Resistance, Is Active across the Range (M0-M7) of Acute Myeloid Leukemia Subtypes (2019) (0)
- Faculty Opinions recommendation of The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis. (2019) (0)
- Clinical nephrology / Glomerulonephritis (2011) (0)
- Granulomatose septique chronique : ce que nous savons et ce que nous ne savons pas encore (2011) (0)
- L'érythropoïèse : un paradigme pour l'étude du rôle des caspases dans la mort et la différenciation cellulaire : Mort cellulaire programmée: Origine(s), mécanismes moléculaires et implications physiopathologiques (2005) (0)
- Faculty Opinions recommendation of SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. (2014) (0)
- The Effectiveness and Safety of Pharmaceutical-Grade Cannabidiol in the Treatment of Mastocytosis-Associated Pain: A Pilot Study (2023) (0)
- Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis. (2022) (0)
- Successful Salvage Therapy By Idelalisib Followed By Haploidentical Allogenic Transplantation of an Alemtuzumab-Refractory T-Cell Prolymphocytic Leukemia (2015) (0)
- Thalidomide in Advanced Mastocytosis. Results from an Open-Label, Multicentric, Phase II Study (2011) (0)
- ATLL introduction: is there a standard of care for treatment of adult T cell Leukemia Lymphoma? (2014) (0)
- The Type of Enteropathy Is a Prognostic Factor in Enteropathy-Associated T-Cell Lymphoma. (2009) (0)
- Comment on Kautz et al , page 2031 Erythroferrone : the missing link in b-thalassemia ? (2015) (0)
- Occurence of Malignancies in Patients with Primary Immunodeficiencies: An Analysis of the French Primary Immunodeficency Registry (2012) (0)
- Clinical, Functional and Genetic Analysis of Twenty-Four Patients with Chronic Granulomatous Disease – Identification of Eight Novel Mutations in CYBB and NCF2 Genes (2012) (0)
- Régression d’une lymphoprolifération CD30+ après traitement antiviral pour une hépatite E chronique (2017) (0)
- CLINICO‐BIOLOGICAL CHARACTERISTICS AND TREATMENT OUTCOMES FOR AGRESSIVE MANTLE CELL LYMPHOMA PATIENTS INCLUDED IN CLINICAL TRIALS. A LYSA STUDY (2019) (0)
- Efficacy and Safety of Masitinib in Corticosteroid-Dependent Severe Asthma: A Randomized Placebo-Controlled Trial (2022) (0)
- 1874 Phase 1b/2 study results for masitinib plus gemcitabine and carboplatin in advanced triple negative breast cancer (2015) (0)
- Reply to K. Ishitsuka et al Treatment of HTLV-I associated adult T-cell leukemia- lymphoma(ATL)remainsachallenge.Ishitsukaetal 1 commentedon (2010) (0)
- A Molecular Classifier Increased the Accuracy of Lymphoma Diagnosis By Expert Pathologists in the Diffuse Large B-Cell Lymphoma Gained Trial from the Lysa (2021) (0)
- Masitinib treatment in patients with progressive multiple sclerosis : Results of an exploratory phase 2 a clinical study (2012) (0)
- Absence de précurseur mastocytaire circulant chez des enfants atteints de mastocytose cutanée (2012) (0)
- Human herpesvirus 8 (HHV8/KSHV) in lymphoproliferative diseases (1998) (0)
- Mast cell-mediated inflammation relies on insulin-regulated aminopeptidase controlling cytokine export from the Golgi (2022) (0)
- Paediatric mastocytosis: a 12‐year follow‐up cohort (2018) (0)
- Iconographies supplémentaires de l'article : Télomères et télomérase : intérêts et perspectives dans le lupus érythémateux systémique (2010) (0)
- Untreated Anemia in Nontransfusion-dependent β-thalassemia: Time to Sound the Alarm (2022) (0)
- Long-Term Effects of Allogeneic Hematopoietic Stem Cell Transplantation on Systemic Inflammation in Sickle Cell Disease Patients (2021) (0)
- Targeted Therapy with Arsenic Trioxide and Interferon alpha Eradicates Leukemic Cells in SCID Mice Model of Adult T-Cell Leukemia/Lymphoma. (2007) (0)
- Érythropoïétine, agent anti-tumoral? (2003) (0)
- Role of TGF-b in malignant hemopathies (2000) (0)
- Erythropoietin Therapy in a Patient Suffering From Retinitis Pigmentosa and Sideroblastic Anemia (2008) (0)
- Minimal Residual Disease Monitoring By 8-Color Flow Cytometry in Mantle Cell Lymphoma Is Complementary to Q-PCR Monitoring and Will Facilitate Pre-Emptive Treatment: An EU-MCL and Lysa Study (2014) (0)
- [Hypereosinophilic syndrome: an entity to be dismembered]. (2005) (0)
- Histological Characteristics Of Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas. Results Of The French Lympho-C ANRS HC-13 Multicentric Study Of 133 Patients (2013) (0)
- Bortezomib As Salvage Treatment for Multiple Myeloma Relapsing after Allogeneic Haematopoietic Stem Cell Transplantation: Efficacy, Tolerance and Modulation of Graft Versus Host Disease: A Study of the French Society for Stem Cell Transplantation and Cell Therapies (SFGM-TC) (2014) (0)
- Tax as a therapeutic target in ATL (2015) (0)
- Clinical Trials and Observations (2006) (0)
- Immunohistochemical Markers Can Be of Predictive Value in Hodgkin’s Lymphoma Response to Treatment. A Preliminary Study of 23 Cases. (2004) (0)
- Abstract 3293: Leptin induces breast cancer metastasis through a Neuropilin-1 (NRP-1)/OBR complex (2014) (0)
- Adult T-cell leukemia/lymphoma in a Caucasian patient after sexual transmission of HTLV-1 (2015) (0)
- Faculty Opinions recommendation of Mast cells are an essential hematopoietic component for polyp development. (2014) (0)
- Erythropoiesis in lower-risk myelodysplastic syndromes and beta-thalassemia. (2022) (0)
- Omalizumab: Efficacy and Safety in Mast Cell Disorders (2018) (0)
- Helicobacter bilis-Associated Suppurative Cholangitis in a Patient with X-Linked Agammaglobulinemia (2017) (0)
- Mastocytose : manifestations digestives (2010) (0)
- Relocalisation of KIT D816V to cell surface after Dasatinib treatment: potential clinical implications (2013) (0)
- Réversibilité complète d'une HTAP sévère dans le cadre d'une infection VIH associée à une maladie de Castleman (2008) (0)
- S209: PRIMARY RESULTS FROM THE PHASE 3 SHINE STUDY OF IBRUTINIB IN COMBINATION WITH BENDAMUSTINE-RITUXIMAB (BR) AND R MAINTENANCE AS A FIRST-LINE TREATMENT FOR OLDER PATIENTS WITH MANTLE-CELL LYMPHOMA (2022) (0)
- Iconography : Ivory vertebra and systemic mastocytosis (2012) (0)
- An Unsuspected Dyserythropoiesis in Gaucher Disease (2014) (0)
- Short Communication Homing Receptor a 4 b 7 Integrin Expression Predicts Digestive Tract Involvement in Mantle Cell Lymphoma (1998) (0)
- Cytopénies auto-immunes périphériques Management of life threatening Immune cytopenia (2005) (0)
- Tax Ubiquitylation and Sumoylation Control the Two Distinct Steps of NF-κB Activation. (2005) (0)
- Maladie de Kaposi révélatrice d’une lymphoprolifération HTLV-1 indolente (2016) (0)
- Abstract 4868: Tyrosine kinase-dependent modulation of tumor infiltrating immune cells in melanoma (2016) (0)
- S143 LUSPATERCEPT INCREASES FETAL HEMOGLOBIN (HBF) LEVELS IN ADULT β-THALASSEMIA PATIENTS WHO REQUIRE RED BLOOD CELL (RBC) TRANSFUSIONS (2019) (0)
- AB0038 IMMUNE PHENOTYPING OF ERDHEIM-CHESTER DISEASE THROUGH MASS CYTOMETRY (2020) (0)
- Human Vδ1+ γδ Peripheral T-Cell Lymphoma/Leukemia are Derived from Natural Killer T (NKT) Cells and Might be Treated with Blocking Anti-CD1d Antibody (2016) (0)
- Malignancy in patients with Ataxia Telangiectasia: results from the French National Registry for Primary Immune Deficiencies, CEREDIH (2010) (0)
- [Treatment of systemic mastocytosis]. (2003) (0)
- Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseases (2021) (0)
- Tax as a therapeutic target in ATL (2015) (0)
- Proposed International Prognostic Scoring System for Mastocytosis (IPSM) (2019) (0)
- Combined Linkage and Association Studies of Antibodies against EBV Antigens Confirm the Role of HLA Class II Variants in the Control of Anti-EBNA1 IgG Levels and in the Risk of Hodgkin's Lymphoma (2014) (0)
- Prognostic value and oncogenic landscape of TP53 alterations in adult and pediatric T-ALL. (2023) (0)
- The pathogenic role of c-Kit+ mast cells in the spinal motor neuron-vascular niche in ALS (2021) (0)
- Lymphome intestinal de bas grade félin : validation d’un modèle spontané et émergent illustrant les lymphoproliférations digestives indolentes à cellules T de l’homme (2020) (0)
- Impact du protocole de coopération « Pose de voie veineuse centrale par l’infirmier » sur la satisfaction et l’anxiété des patients bénéficiant de la pose d’une chambre implantable dans un centre hospitalier régional universitaire français (2019) (0)
- Molecular Mechanisms of NF-kappaB Activation by the HTLV-I Oncoprotein Tax: Role of Post Translational Protein Modification. (2007) (0)
- Recurrent TET2 mutations in adult T cell leukemia (ATL) and identification of a Single Nucleotide polymorphism in TET2 region predisposing to ATL development (2015) (0)
- PS1251 CLINICO-BIOLOGICAL CHARACTERISTICS AND TREATMENT OUTCOMES FOR BLASTOID MANTLE CELL LYMPHOMA PATIENTS INCLUDED IN CLINICAL TRIALS. A LYSA STUDY (2019) (0)
- [The interest of administering intravenous immunoglobulins to adults at home]. (2004) (0)
- Correction: Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial (2023) (0)
- Hepatis C virus related non-Hodgkin’s lymphomas (2000) (0)
- Faculty Opinions recommendation of Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers. (2014) (0)
- Nodular regenerative hyperplasia : The main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities q (2007) (0)
- 3 Structure-based discovery of a small non-peptidic Neuropilins 4 antagonist exerting in vitro and in vivo anti-tumor activity on breast (2014) (0)
- High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network (2022) (0)
- 72PThe immune modulation role of low dosage of cyclosporin-A (ldCSA) in the antitumor response of CD8+ T lymphocytes (CD8+Tcells) and the implication of neuropilin-1 (Nrp1) (2017) (0)
- High-Resolution Whole-Genome Copy Number Profiling Identifies High-Risk and Low-Risk Patients with Mantle Cell Lymphoma, a Result of the Lyma-Genomic Project Conducted on Behalf the Lysa Group (2016) (0)
- Autoévaluations de l'article : Mastocytose : manifestations digestives (2010) (0)
- Faculty Opinions recommendation of Preclinical human models and emerging therapeutics for advanced systemic mastocytosis. (2019) (0)
- Outcome of Patients with Primary Mediastinal Large B-Cell Lymphoma after R-CHOP21, R-CHOP14 and R-ACVBP: A Pooled Analysis of Clinical Trials from Lysa (2022) (0)
- Faculty Opinions recommendation of Tryptase-positive mast cells predict clinical outcome of patients with early B-cell chronic lymphocytic leukemia. (2014) (0)
- Enterobacter cloacae pyomyositis complicating chronic granulomatous disease and review of gram-negative bacilli pyomyositis (2013) (0)
- Type I interferon-mediated autoinflammation due to DNase II deficiency (2017) (0)
- S1252 Presentation and Long Term Follow-Up of Refractory Celiac Disease (RCD): Comparison of Rcd of Type I with Rcd of Type II (2008) (0)
- Role of GATA-1 and HSP70 in the Dyserythropoiesis of Early Myelodysplastic Syndromes. (2009) (0)
- HTLV-I leukemogenesis signaling in human T cells via c-Jun activation: a potential mechanism of Human T cell lymphotropic virus oncoprotein tax represses TGF-ß1 (2013) (0)
- Hypogammaglobulinemia during Rituximab Maintenance after Transplantation Is a Surrogate Marker for Disease Control in Patients with Mantle-Cell Lymphoma, an Analysis from the LyMa Trial (2020) (0)
- Mast Cell Disease and Blood Coagulation Abnormalities: Discussion on 14 Cases and Review of the Literature (2014) (0)
- PosaconazoleCushing's Syndrome Induced by (2014) (0)
- HSP70, the Key to Account for Erythroid Tropism of Diamond-Blackfan Anemia? (2015) (0)
- Iconography : Mast cells and inflammation (2012) (0)
- Can we cure ATL: new drugs and targeting ATL stem cells (2014) (0)
- Chronic Granulomatous Disease In Patients Reaching Adulthood: A Nationwide Retrospective Study Of 80 Cases In France (2013) (0)
- Targeting Serotonin With Common Antidepressants Induces Rapid Recovery From Cytopenia (2022) (0)
- JNK Pathway Is Constitutively Activated and Is Required for Survival in Human Mantle-Cell Lymphoma Fresh Cells and Cell-Lines. (2006) (0)
- Development and Validation of a Sensitive Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Assay for the Simultaneous Quantification of Midostaurin (PKC412) and Its Two Major Metabolites: A Suitable Tool for the Monitoring of the Drug in Patients Suffering From Advanced Systemic Mastocytosi (2012) (0)
- The combination of arsenic, interferon-alpha, and zidovudine restores an “immunocompetent-like” cytokine expression profile in patients with adult T-cell leukemia lymphoma (2013) (0)
- Evidence for Three Distinct Classes of Phenotype Severity in Beta-Thalassaemia (2019) (0)
- angiogenesis and establish functional gap junctions with endothelial cells transformed cells induce - Human T-cell lymphotropic virus type 1 (2013) (0)
- overexpression of the chemokine I-309 Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by (2010) (0)
- C-kit inhibitors (2002) (0)
- Lack of Detection of FIP1L1-PDGFRA Gene Fusion in a Cohort of Mastocytosis with Eosinophilia. (2005) (0)
- Hairy Cell Leukemia: Results of the French Retrospective Cohort After 10 Years of Follow Up (2019) (0)
- Frontline Therapy in Mantle Cell Lymphoma: New Standards in 2017 (2017) (0)
- [Self-sufficiency, needs, prescription and safety of blood products]. (2013) (0)
- Tax as a therapeutic target in ATL (2015) (0)
- A deep dive into future therapies for microcytic anemias and clinical considerations. (2023) (0)
- Masitinib in comparison to imatinib as first-line therapy of patients with advanced gastrointestinal stromal tumor (GIST): A randomized phase III trial. (2012) (0)
- Identification of serotonin as a gut regulator of liver hepcidin expression (2023) (0)
- L’absence d’expression du CD2 sur les mastocytes médullaires détermine un nouveau sous-type nosologique de mastocytose agressive : étude d’une cohorte de 85 patients (2012) (0)
- Masitinib for the treatment of Alzheimer’s disease: clinical and preclinical data (2016) (0)
- [Roundtables of SFTS Congress 2013: Needs, indications and safety of blood products; self-sufficiency in blood products]. (2014) (0)
- Decrease of cocaine, but not heroin, self-administration and relapse by the tyrosine kinase inhibitor masitinib in male Sprague Dawley rats (2018) (0)
- Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma (2021) (0)
- Reply to K. Ishitsuka et al (2010) (0)
- Immunology of Hematopoietic Stem Cell Transplantation (2022) (0)
- Serotonin Targeting Using Common Antidepressants Induces Rapid Recovery of Cytopenia (2019) (0)
- Spectre clinique et histopathologique de l’atteinte rénale au cours des vascularites cryoglobulinémiques mixtes d’origine non-infectieuse (2012) (0)
- l'Adulte (GELA) non- Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de Prognostic significance of bcl-2 protein expression in aggressive (2002) (0)
- European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives. (2023) (0)
- Human erythroleukemia: is the two-hit model of mouse leukemogenesis valid in human disease? (2007) (0)
- Le phénotype et le génotype des mastocytoses diffèrent selon l'âge de début (2006) (0)
- Iconography : Mastocytes et inflammation (2013) (0)
- Erdheim–Chester disease long‐bone osteosclerosis can be reproduced with a xenografted mouse model and its pathogenesis may involve dysregulation of bone metabolism key cytokines (2022) (0)
- Investigations into the Mechanisms and Clinical Implications of Modulation of Hepcidin Levels By Luspatercept in TD MDS and TD b-Thalassemia (2022) (0)
- Phase 2, Randomized, Double-Blind, Placebo Controlled Study of Inecaclcitol Combined with Decitabine versus Decitabine: A New Treatment Strategy for Elderly AML Patients Unfit for Intensive Chemotherapy (2017) (0)
- Topoisomerase 2 b mutation impairs early B cell development (2020) (0)
- Procédés pour prédire la réactivité d'un patient atteint d'une maladie hématologique maligne à un traitement par chimiothérapie et procédés de traitement de ces maladies (2016) (0)
- Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis (2016) (0)
- P53 and P16 Protein Expression Have Prognostic Value in Mantle Cell Lymphomas in the Lyma Trial in the Lysa Group (2017) (0)
- Mast cells in spondyloarthritis, more than simple inflammatory bystanders? (2020) (0)
- Tax as a therapeutic target in ATL (2015) (0)
- [Hypophosphatemia complicated with neurological manifestations during hematopoietic reconstitution]. (2012) (0)
- Association of Deferasirox and Vitamin D Promotes Cell Differentiation and Improves Overall Survival in Acute Myeloid Leukemia (AML) Elderly Patients After Demethylating Agents Failure: A Retrospective Case Control Study (2012) (0)
- Long term favourable evolution of a 28-years old patient with transcobalamin II deficiency (2001) (0)
- Prospective Multicenter Study for Evaluating Cognitive Disorders in Hematology-Oncology: A Pilot Study of 118 Patients (2008) (0)
- Epstein-Barr Virus: Main Pathogenic Agent in Hodgkin Lymphoma Associated Hemophagocytic Syndrome?. (2007) (0)
- Hematopoietic Multipotent Progenitor Cells Mobilized by G-CSF Can Inhibit Gvhd (2011) (0)
- [Systemic mastocytosis]. (2005) (0)
- Humoral immune depression following autologous stem cell transplantation is a marker of prolonged response duration in patients with mantle cell lymphoma (2022) (0)
- Déficit en transcobalamine II : une cause rare d'anémie macrocytaire (2001) (0)
- Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up (2020) (0)
- [Anatomo-clinical conference. Pitié-Salpêtrière Hospital. Case No 3--1997. Febrile pancytopenia]. (1997) (0)
- INTRAEPITHELIAL LYMPHOCYTOSIS QUANTIFICATION BY MACHINE LEARNING IN CELIAC DISEASE. A CELAC STUDY (2022) (0)
- The orphan GPR50 receptor promotes constitutive TGFβ receptor signaling and protects against cancer development (2018) (0)
- Amyloidosis: Round Table (2003) (0)
- Brief Common variable immunodeficiency is associated with defective functions of dendritic cells (2004) (0)
- Rôle du pathologiste dans le diagnostic de la maladie cœliaque et de ses complications (2018) (0)
- Deciphering the molecular basis of arsenic/interferon-alpha induced eradication of leukemia initiating cells in adult T cell leukemia (2015) (0)
- Faculty Opinions recommendation of Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. (2014) (0)
- Exploring the genetic landscape of HCV-related B-cell lymphomas using whole exome sequencing. (2023) (0)
- Tocilizumab Plus Dexamethasone in Patients with Moderate-to-Severe COVID-19 Pneumonia: a Randomized Clinical Trial of the CORIMUNO-19 Study Group (2021) (0)
- POEMS syndrome: still an enigma? (2013) (0)
- Mastocytose cutanée : analyse longitudinale d’une cohorte pédiatrique au statut mutationnel KIT connu (2013) (0)
- La leucémie à mastocytes : description des principales caractéristiques clinico-biologiques et évolutives à partir de 51 cas : les 47 cas publiés dans la littérature internationale et quatre cas français (2012) (0)
- Traitement par immunoglobulines intraveineuses des syndromes d’activation macrophagique d’étiologie infectieuse : analyse de 32 cas (2010) (0)
- Autologous Stem Cell Transplantation (HCT) with or Without Total Body Irradiation (TBI) in Newly Diagnosed Mantle Cell Lymphoma (MCL) Patients (2012) (0)
- Correction to: A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency (2020) (0)
- PIM2 Pro-Survival Functions Are Mediated By RSK2 in AML (2014) (0)
- The combination of arsenic, interferon-alpha, and zidovudine restores an “immunocompetent-like” micro-environment in patients with adult T-cell leukemia lymphoma (2014) (0)
- Poor Prognosis Associated with Gains of CCND1 in Mantle Cell Lymphoma Treated By First Line Immuno-Chemotherapy — a Study By the Lysa Group (2018) (0)
- Foxp3+ Regulatory Cells Suppressive Human Invariant NKT Cells into Converts β Rapamycin Combined with TGF- (2013) (0)
- Adult T-cell leukemia and lymphoma in French Guiana: a retrospective analysis with real-life data from 2009 to 2019 (2023) (0)
- Masitinib Shows Prolonged Survival in Amyotrophic Lateral Sclerosis (ALS) Patients with Mild or Moderate Disease Severity at Baseline (S33.003) (2023) (0)
- Faculty Opinions recommendation of Variability of PD-L1 expression in mastocytosis. (2019) (0)
- Can we cure HTLV-I associated Adult T cell Leukemia Lymphoma? (2011) (0)
- The Multidrug Transporter MRP4/ABCC4 Involved in the Leukemia Clinical Course Specifies the Novel PEL Human Blood Group System (2019) (0)
- Chronic adult T-cell Leukemia in a young male after blood transfusion as a newborn (2016) (0)
- HTLV-1/BLV antisense-RNA dependent host gene perturbation in pre-leukemic and leukemic clones (2015) (0)
- GENETIC DIAGNOSIS GUIDES TREATMENT OF AUTOIMMUNE ENTEROPATHY. (2022) (0)
- Cutaneous mastocytosis in adults with a serum tryptase level < 20 ng mL–1: why we should investigate further (2021) (0)
- Minimal residual disease (MRD) is a predictor of clinical outcome in elderly patients with MCL and identifies patients with long lasting remissions after R-CHOP or R-FC induction followed by maintenance with rituximab or IFN (2011) (0)
- Anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) or investigator's choice in subjects with relapsed or refractory adult T-cell leukemia-lymphoma (ATL) (2015) (0)
- deficiency A Mendelian predisposition to B-cell lymphoma caused by IL-10R (2013) (0)
- ILDS Newsletter No. 12/2010 (2010) (0)
- 2349 Phase 1b/2 study results for masitinib plus irinotecan in second-line treatment of esophagogastric adenocarcinoma (2015) (0)
- Disseminated toxoplasmosis in non-allografted patients with hematologic malignancies: report of two cases and literature review (2013) (0)
- p53-dependent senescence Persistent inhibition of telomerase reprograms adult T-cell leukemia to (2013) (0)
- Identification of Previously Unrecognized CD1d-Restricted Peripheral T Cell Lymphomas (PTCLs) in Mouse and Human Reveals Blocking Anti-CD1d Monoclonal Antibodies As a New Therapeutic Possibility in PTCLs (2014) (0)
- Mobilized Multipotent Hematopoietic Progenitors Promote Expansion and Survival of Allogeneic Tregs and Protect Against Graft Versus Host Disease (2021) (0)
- Lack of the human choline transporter-like protein CTL2 causes hearing impairment and a rare red blood cell phenotype (2022) (0)
- Erratum to: Clinical, Functional and Genetic Analysis of Twenty-Four Patients with Chronic Granulomatous Disease—Identification of Eight Novel Mutations in CYBB and NCF2 Genes (2012) (0)
- RITUXIMAB IN COMBINATION WITH BENDAMUSTINE OR HIGH‐DOSE CYTARABINE‐BASED INDUCTION THERAPY IN TRANSPLANT‐ELIGIBLE PATIENTS WITH MANTLE CELL LYMPHOMA (2021) (0)
- Sputum IL-6 level as a potential predictor of acute chest syndrome during vaso-occlusive crisis in children with sickle cell disease: Exploratory prospective prognostic accuracy study. (2023) (0)
- Efficacy and Safety of Rituximab in Common Variable Immunodeficiency-Associated Immune Cytopenias: a Retrospective Analysis of 10 Cases. (2009) (0)
- Longitudinal Evolution and Clinical Impact of Subclonal Mutational Architecture in Adult T Cell Leukemia/Lymphoma (2018) (0)
- systemic mastocytosis and behaves like a mast cell precursor cell rate correlates with aggressive forms of + c-Kit - Blood CD34 (2012) (0)
- High Level of CD71 Expression On Neoplastic B Cells At Diagnosis Is Predictive of Overall Survival After Rituximab and Anthracyclines Based Regimen in Follicular Lymphoma (2012) (0)
- Faculty Opinions recommendation of How we diagnose and treat systemic mastocytosis in adults. (2019) (0)
- Primary cells from patients with adult T cell leukemia/lymphoma depend on HTLV-1 Tax expression for NF-κB activation and survival (2023) (0)
- Faculty Opinions recommendation of A comparison of clinical and molecular characteristics of patients with systemic mastocytosis with chronic myelomonocytic leukemia to CMML alone. (2019) (0)
- Polymeric Immunoglobulin A1 Controls Erythroblast Proliferation and Accelerates Erythropoiesis Recovery in Anemia (2011) (0)
- Dynamic changes within the mononuclear phagocyte system reveal an alternative differentiation pathway for Ly6C(+) monocytes (2014) (0)
- Allogeneic Hematopoietic Stem Cell Transplantation Achieves Long-Term Survival in Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Analysis of the EBMT Lymphoma Working Party (2022) (0)
- in vivo and in vitro expression is critical for mouse erythroid maturation PIT1 EKLF-driven (2013) (0)
- [Parathormone and erythropoiesis]. (2011) (0)
- Pathogenesis and new therapeutic approaches in HTLV-1 associated lymphoproliferative disorders (1996) (0)
- Anticorps anti-tfr (2004) (0)
- pathophysiology of Gaucher disease Abnormal properties of red blood cells suggest a role in the (2013) (0)
- Respiratory Status After Hematopoietic Stem Cell Transplantation for Primary Immunodeficiency (2023) (0)
- New Peptides Structurally Related to VEGF-A165 Exon-7 and -8 Encoded Domains Antagonize Its Binding to NRP-1 and VEGF-R1 (2014) (0)
- Anémie et chimiothérapie des hémopathies malignes (2003) (0)
- Masitinib dans le traitement de la mastocytose systemique sévère de forme indolente ou latente : un essai clinique de phase 3 randomisé et controllé☆ (2016) (0)
- Leucémie/lymphome T de l’adulte à HTLV-1 associée à une vascularite paranéoplasique (2018) (0)
- Flushs sans urticaire pigmentaire au cours de la mastocytose systémique : étude de 9 cas (2012) (0)
- Recurrent TET2 mutations in adult T cell leukemia (ATL) and identification of a Single Nucleotide polymorphism in TET2 region predisposing to ATL development (2015) (0)
- Efficacité et tolérance à long terme de la cladribine (2-CdA) dans les mastocytoses de l’adulte : une étude française multicentrique de 68 patients (2013) (0)
- Combination of the MEK Inhibitor Trametinib and Pyrvinium Pamoate Efficiently Targets RAS Pathway-Mutated Acute Myeloid Leukemia in Preclinical Models (2019) (0)
- The complement system is activated after allogeneic bone marrow transplantation and might early predict the development of gastrointestinal graft versus host disease (2008) (0)
- Focus on Treatment of HTLV-I-Associated Adult T-Cell Leukemia/Lymphoma (2014) (0)
- Évolution des lymphomes B non-hodgkiniens associés au virus de l’hépatite C en France, données cliniques de l’étude ANRS HC-13 Lympho-C (2011) (0)
- reliable markers of ALPS associated with FAS loss of function FAS-L, IL-10, and double-negative CD4-CD8-TCR alpha/beta+ T cells are (2011) (0)
- Évaluation de l’efficacité virologique et de la tolérance du traitement antiviral chez les patients porteurs d’une hépatite C chronique, associée à un lymphome B non hodgkinien : étude cas-témoins ANRS HC13 lympho-C (2014) (0)
- Le syndrome d’activation mastocytaire idiopathique pédiatrique : une nouvelle entité (2021) (0)
- Mastocytes et inflammation (2013) (0)
- Présentation atypique de rates accessoires en immunohématologie : série de 5 cas (2009) (0)
- Dépression au cours de la mastocytose : étude de la prévalence, des caractéristiques chez 288 patients et efficacité d’un traitement par masitinib (2011) (0)
- Sarcomes mastocytaires : série de cas français et revue de la littérature (2015) (0)
- Leucémie agressive à grands lymphocytes à grains CD3+, CD56- circulants contrastant avec une prolifération médullaire et ganglionnaire non granuleuse de phénotype T plus immature (1996) (0)
- HIGH‐RISK MANTLE CELL LYMPHOMA IN THE LYMA TRIAL: A LYSA STUDY (2021) (0)
- Rationnel et efficacité du ciblage thérapeutique de l’Interleukine (IL)–1 dans la maladie d’Erdheim-Chester (2011) (0)
- Lymphoproliferative Disease in Wiskott-Aldrich Syndrome: Analysis of the French National Registry of Primary Immunodeficiencies (2014) (0)
- Phenotypic and Functional Characterization Of a Novel Immature Hematopoietic Myeloid Suppressive Progenitor Cells Mobilized By G-CSF. Application To Gvhd Treatment (2013) (0)
- Abstract 14505: An Early Transcriptomic Signature Predicts Poor Outcome After Out-of-hospital Cardiac Arrest (2017) (0)
- Intérêts du phénotype sanguin au cours de la mastocytose systémique : résultats de l’étude de 51 patients (2008) (0)
- Syndrome myélodysplasique et cirrhose cryptogénique comme causes de cytopénies inexpliquées ou de monocytose chronique dans la fièvre méditerranéenne familiale (2019) (0)
- Mutation du gène UBA1 dans l’artérite à cellules géantes (2021) (0)
- Contribution of Imaging Flow Cytometry to Storage Lesion Assessment: Identification of a Sub-Population of Morphologically Altered Erythrocytes (2015) (0)
- L’ostéoporose n’est pas une caractéristique fréquente des patients avec une mastocytose systémique prédiagnostique (2020) (0)
- Un cas de mastocytose systémique chez un enfant avec anomalies morphologiques : hypothèses physiopathologiques☆ (2016) (0)
- Augmentation des taux plasmatiques d’histamine chez les patients atteints de drépanocytose (2018) (0)
- Caractéristiques des vascularites cryoglobulinémiques monoclonales de type I : données de l’enquête nationale CryoVas (2010) (0)
- Anal ulceration in a young man (2009) (0)
- Rôle du TGF-b dans les hémopathies malignes (2000) (0)
- Efficacité d’un nouvel inhibiteur de tyrosine kinase dans une forme agressive de mastocytose (la leucémie à mastocytes) et identification d’une nouvelle mutation du gène c-Kit (2009) (0)
- Clonal B-Cell Lymphocytosis with Marginal Zone Features and Splenic Marginal Zone Lymphoma Share a Similar Cytogenetic and Mutational Profile (2016) (0)
- Une étiologie de syndrome d'activation macrophagique : Le virus HTLV-1 (2003) (0)
- Iconographies supplémentaires de l'article : Ivory vertebra and systemic mastocytosis (2012) (0)
- Traitement d’un lymphome agressif chez un babouin naturellement infecté par STLV-1 (2015) (0)
- Identification o f P rognostic F actors i n 6 1 P atients W ith Posttransplantat ion L ymphoproliferat ive D isorders (2001) (0)
- Northern African strains of human T-lymphotropic virus type 1 arose from a recombination event (2015) (0)
- Faculty Opinions recommendation of A distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis. (2019) (0)
- Optimisation transfusionnelle : étude de la lésion de stockage par cytométrie morphologique (AMNIS°) et microsphiltration (2015) (0)
- Caractéristiques des vascularités cryoglobulinémiques monoclonales de type I : données de l’enquête nationale CryoVas (2011) (0)
- Médecine interne/Hématologie - Les mastocytoses systémiques (2008) (0)
- Implication des mastocytes dans la fièvre méditerranéenne familiale : une étude prospective sur 50 patients (2017) (0)
- La cladribine améliore les manifestations cutanées, la qualité de vie dermatologique et spécifique des patients adultes avec mastocytose : étude rétrospective de 16 patients du CEREMAST (2020) (0)
- S267: PROPERDIN-BLOCKING ANTIBODIES ATTENUATE COMPLEMENT ALTERNATIVE PATHWAY ACTIVATION TRIGGERED BY CELL-FREE HEME IN SICKLE CELL DISEASE MODELS (2022) (0)
- [Chronic asthenia and abdominal pain in a 26-year-old woman]. (2017) (0)
- Mise à jour des recommandations EULAR sur l’utilisation des thérapies immunomodulatrices dans la prise en charge de la Covid-19 (2021) (0)
- Prévalence et caractéristiques cliniques de la mastocytose télangiectasique : analyse d’une cohorte de mastocytoses (2013) (0)
- Erratum to: Adult T-Cell Leukaemia/Lymphoma (ATL) (2015) (0)
- Facteurs cliniques et moléculaires associés à la régression de la mastocytose : étude d’une cohorte de 272 enfants (2019) (0)
- Efficacité et sécurité de l’avapritinib (AVA) chez les patients atteints de mastocytose avancée (AdvSM) : résultats intermédiaires de l’étude PATHFINDER de phase 2 (2021) (0)
- Vertèbre ivoire et mastocytose systémique (2012) (0)
- Emm : un nouveau système de groupe sanguin associé à des troubles neurodéveloppementaux (2021) (0)
- « Masque ta fatigue : ce ne sont pas les vitamines ! » (2017) (0)
- Transformed Cells - Apoptosis in Human T-Cell Lymphotropic Virus Type I Arsenic Trioxide and Interferon-? Synergize to Induce Cell Cycle Arrest and (2013) (0)
- Mastocytose et aliments (2017) (0)
- KIR3DL2 IS EXPRESSED IN PERIPHERAL T‐CELL LYMPHOMAS AND MAY BE A THERAPEUTIC TARGET (2019) (0)
- Absence d'augmentation du risque de lymphome sous anti-TNFa: résultats de l'observatoire prospectif RATIO sur 16 cas de lymphomes sous anti TNFa en deux ans en France (2006) (0)
- Efficacité des immunoglobulines IV au cours d’une polymyosite à HTLV1 (2013) (0)
- Dilatations des bronches chez les adultes atteints de déficits immunitaires héréditaires humoraux diagnostiqués dans l’enfance (2017) (0)
- Évolution radiologique favorable d'atteinte osseuse d'une maladie d'Erdheim-Chester sous anakinra (2013) (0)
- CO028Amylose cardiaque : description d’une série de 14 cas (2011) (0)
- Manifestations auto-immunes et inflammatoires associées aux syndromes myélodysplasiques avec trisomie 8 : étude cas-contrôles française rétrospective (2018) (0)
- Serotonin regulates hepcidin expression via a gut-liver axis (2021) (0)
- Hématomes sous-cutanés multiples chez une femme de 35 ans (1997) (0)
- Mastocytose du sujet âgé : à propos de 195 patients dont 80 cas français et 115 cas issus de la littérature (2013) (0)
- Anomalies hématologiques. Evaluations cliniques et paracliniques chez les sportifs (2005) (0)
- Progressive Multifocal Leukoencephalopathy in Primary Immunodeficiencies (2018) (0)
- Les manifestations respiratoires de la maladie de Bruton chez l'adulte. A propos de 10 cas (2008) (0)
- RETRAIT: Lymphomes T intestinaux associés à une entéropathie (maladie cœliaque et sprue réfractaire): présentation, diagnostic, prise en charge thérapeutique, pronostic et perspectives (2010) (0)
- 36e congrès de la Société Américaine d'Hématologie Nashville, TN, 2 au 6 décembre 1994 (1995) (0)
- L’ataxie-télangiectasie : évolution à long terme et risque néoplasique Étude du registre du centre de référence des déficits immunitaires héréditaires (CEREDIH) (2011) (0)
- Association between hepatitis C virus and non-hodgkin's lymphomas. Authors' reply (2006) (0)
- Syncopes et décès cardiovasculaires dans la mastocytose systémique (2015) (0)
- Improved high throughput DNA-seq based mapping of HTLV-1 integration sites: a tool to define response to treatment, ATL prognosis and guide therapeutic strategies (2017) (0)
- Rechute neuroméningée mortelle après greffe de moelle allogénique au cours d'une leucémie-lymphome à HTLV-1 mise en rémission complète par AZT et Interferon alpha (1998) (0)
- Facteurs associés à la mortalité à J30 dans l’hémophagocytose lymphohistiocytaire chez l’adulte : construction d’un score de mortalité à partir d’une cohorte multicentrique de 170 patients et validation sur une cohorte de 118 patients (2020) (0)
- S1268 Digestive Symptoms in Mastocytosis (2008) (0)
- Efficacy of a short sandwich protocol, methotrexate, gemcitabine, L‐asparaginase and dexamethasone chemotherapy combined with radiotherapy, in localised newly diagnosed NK/T‐cell lymphoma: A French retrospective study (2023) (0)
- Procédés et compositions pharmaceutiques pour le traitement de maladies induites par la voie de signalisation du complexe nrp-1/obr (2015) (0)
- Scepticisme de l'abcès! (2002) (0)
- L’efficacité d’une transfusion en globules rouges est-elle modulée par l’état physiopathologique du receveur ? (2019) (0)
- Purpura thrombopénique immunologique et déficit immunitaire commun variable: analyse de 22 cas (2001) (0)
- OP0053 Inflammatory disorders associated with trisomy 8 myelodysplastic syndromes : french retrospective case control study (2018) (0)
- Décès survenant au cours de l’hémophilie acquise en France : analyse en causes multiples pour une amélioration des stratégies de prise en charge (2011) (0)
- Troubles cognitifs au cours de la mastocytose : étude de la prévalence, des caractéristiques chez 57 patients (2012) (0)
- Jean-Claude Brouet (2022) (0)
- Success of interferon α therapy in a patient with hepatitis C virus-negative splenic marginal zone lymphoma associated with polycythemia vera (2015) (0)
- Rationnel et efficacité du ciblage du CD52 dans la myosite associée au HTLV-1☆ (2014) (0)
- Intérêt de l’ immunomarquage CD30 cutané dans les mastocytoses systémiques : cohorte de 27 patients (2016) (0)
- Autoévaluations de l'article : Lymphomes non hodgkiniens T et NK périphériques (2014) (0)
- Iconografie supplementari dell'articolo : Anemia emolitica (2009) (0)
- 37e congrès de la Société Américaine d'Hématologie Seattle, WA, 1er au 5 décembre 1995 (1996) (0)
- Intérêt de l’administration à domicile des immunoglobulines intraveineuses chez l’adulte (2004) (0)
- Utilisation des immunoglobulines intraveineuses et sous-cutanées chez des patients atteints de déficits Immunitaires secondaires : analyse rétrospective (ULTIMATE) (2018) (0)
- Reply to Owen et al (2003) (0)
- Mantle cell lymphoma treatment: plus ça change… (2016) (0)
- @@112053@@ : Syndrome mononucléosique (2009) (0)
- ATLL introduction: is there a standard of care for treatment of adult T cell Leukemia Lymphoma? (2014) (0)
- Complement System Activation after Allogeneic Bone Marrow Transplantation May Early Predict the Development of Acute Gastrointestinal GVHD. (2007) (0)
- Informations au patient de l'article : Mastocytoses (2007) (0)
- Pneumopathies interstitielles non infectieuses post allogreffe de cellules souches hématopoïétiques : série de 40 patients explorés à l’hôpital Foch (2018) (0)
- Iconographies supplémentaires de l'article : Mastocytoses (2007) (0)
- Intérêt du séquençage complet du gène KIT dans la prise en charge des mastocytoses pédiatriques sévères (2017) (0)
- Maladie cœliaque, sprue réfractaire et lymphome (2002) (0)
- Polypeptides capables d'inhiber la liaison entre la leptine et la neuropiline-1 (2016) (0)
- Premières Journées de la Lymphoma Study AssociationDeauville, 10-12 octobre 2013Partie 1 (2013) (0)
- Nouvelle entité au sein de la mastocytose avec très mauvais pronostic et associée à la négativité du CD2 sur les mastocytes médullaires : étude d’une cohorte de 85 patients (2012) (0)
- Étiologies et orientation diagnostique devant un flush Causes and differential diagnosis of flush (2014) (0)
- L’adhérence érythrocytaire à l’endothélium vasculaire humain est augmentée dans les occlusions de veine centrale de la rétine (2010) (0)
- Histiocytoses langerhansiennes systémiques de l'adulte : 25 observations (1998) (0)
- Error in Sample Size. (2021) (0)
- Anémies réfractaires: la place des facteurs de croissance hématopoïétique (1995) (0)
- Iconography : Anémie macrocytaire (2009) (0)
- Une épidurite compressive et des lésions osseuses multiples révélant une mastocytose inclassable 20 ans après une tumeur germinale non séminomateuse du médiastin : une association non fortuite (2014) (0)
- Caractéristiques clinicobiologiques, facteurs pronostiques et prise en charge thérapeutique du scléromyxœdème : étude rétrospective multicentrique (2017) (0)
- Le trioxyde d'arsenic : un intérêt potentiel dans le traitement des lymphoproliférations T causées par le virus HTLV-1 (1999) (0)
- Granulomatose chronique et auto-immunit : propos d'un cas (2001) (0)
- Réactions cutanées aux inhibiteurs de tyrosine kinase utilisés en protocole dans les mastocytoses sévères : à propos de cinq cas (2012) (0)
- La lymphadénopathie angio-immunoblastique (2000) (0)
- Immune Profile of Sickle Cell Anemia Patients Treated with Allogeneic Stem Cell Transplantation (2017) (0)
- Le pourcentage de macrophages et le nombre des mastocytes et lymphocytes TiA1+ sont des biomarqueurs du caractère réfractaire primaire ou d’une rechute précoce dans les lymphomes de Hodgkin classiques (2011) (0)
- Immunoglobuline A1 - Le système immunitaire au secours de l’érythropoïèse (2012) (0)
- Analyse fonctionnelle des anomalies de la moésine dans les lymphomes NK/T (2022) (0)
- Implication de la voie de signalisation Hedgehog dans les mastocytoses (2020) (0)
- La tryptase médullaire, un nouveau critère diagnostique de l’atteinte systémique de la mastocytose : étude multicentrique prospective (2020) (0)
- Mastocytoses systémiques avec taux de tryptase inférieur à 20 μg (2014) (0)
- Manifestations pulmonaires chez les patients adultes avec syndrome hyper IgE STAT3 muté : résultats de la cohorte française (2018) (0)
- S210: CAR T-CELLS ASSOCIATED ACUTE TOXICITY IN B-CELL NON-HODGKIN LYMPHOMA: REAL-WORLD STUDY FROM THE DESCAR-T REGISTRY (2022) (0)
- Chocs anaphylactiques et mastocytose systémique : étude de 11 cas (2012) (0)
- Errors in Group Information Supplement. (2021) (0)
- Neuropilin-1 is a cofactor for HLV entry. (2006) (0)
- Les anomalies chromosomiques dans les proliférations lymphoïdespost-transplantation (2000) (0)
- Hypophosphorémie compliquée de troubles neurologiques en sortie d’aplasie (2012) (0)
- Étude rétrospective de l’impact de l’allogreffe de cellules souches hématopoïétiques sur les complications pulmonaires chez les patients avec un déficit immunitaire primitif (2023) (0)
- Devenir des patients atteints de granulomatose septique chronique à l’âge adulte. Une étude rétrospective nationale de 80 cas (2014) (0)
- Détection de différents rétrovirus chez des primates non-humains infectés par STLV-1 ou SFV et pathologie viro-induite (2015) (0)
- Peut-on remplacer la biopsie ostéomédullaire par un myélogramme avec phénotypage pour établir le diagnostic de mastocytose systémique avec atteinte médullaire ? Résultats de l’étude de 24 patients (2009) (0)
- Fractures osseuses dans la mastocytose : analyse d’une cohorte de patients (2014) (0)
- La classification OMS des lymphomes et son avenir (2003) (0)
- Efficacité de la Thalidomide dans les manifestations inflammatoires de la granulomatose septique chronique (2011) (0)
- Autoévaluations de l'article : Mastocytoses (2007) (0)
- Oligoarthrite, hippocratisme digital et lésions cutanées (1996) (0)
- Evolution favorable à long terme du déficit congénital en transcobalamine II à propos d'un patient de 28 ans (2001) (0)
- Intensification thérapeutique et autogreffe de moelleau cours des maladies auto-immunes (2002) (0)
- Maladies neuro-inflammatoires associées à la mastocytose : série de 8 cas (2016) (0)
- Résultats définitifs à trois ans de l'observatoire national prospectif RATIO chez les patients traités par anti TNF: absence d'augmentation du risque de lymphome non Hodgkinien mais petite augmentation des lymphomes de Hodgkin ou Hodgkin like associés à l'EBV (2007) (0)
- Improving the methodology for the detection of proviral integration sites in the host genome via high throughput sequencing (2015) (0)
- Le sarcome mastocytaire, une entité rare et très agressive : description d’une série de 8 cas (2011) (0)
- Amylose immunoglobulinique : Amyloses (1997) (0)
- Efficacité et tolérance du rituximab dans les cytopénies auto-immunes associées aux déficits immunitaires avec hypogammaglobulinémie : analyse rétrospective d’une série de 16 cas (2009) (0)
- Treatment of an aggressive STLV-1 associated lymphoma in a naturally infected baboon (2015) (0)
- Risque infectieux de l’étoposide dans l’hémophagocytose lymphohistiocytaire de l’adulte (2020) (0)
- Caractéristiques en TEP au 18F-FDG des mastocytoses systémiques (2013) (0)
- Invariant NKT Cells Producing Capacity of Human - IL-17 Proinflammatory Environment Dictates the (0)
- Traitement d'une maladie coeliaque (2015) (0)
- Diminution du tryptophane et élévation des taux de kynurénines plasmatiques au cours de la mastocytose avec atteinte digestive (2015) (0)
- Neurological Involvement in Childhood Evans Syndrome (2019) (0)
- Maladie du pool vide et myélofibrose idiopathique chez une femme de 73 ans: une association rare (1997) (0)
- L-Asparaginase in the Treatment of Relapsing Nasal/Nasal Type NK-T-Cell Lymphoma. (2004) (0)
- Health-related quality of life in patients with β-thalassemia: Data from the phase 3 BELIEVE trial of luspatercept. (2023) (0)
- Utilisation d'hydroxycarbamide pour prevenir la non-perfusion retinienne (2016) (0)
- [Regulation of erythropoiesis mediated by immunoglobulin A1]. (2012) (0)
- The Inhibitor of VEGF-Receptors Tyrosine Kinase PTK-787 Blocks the Invasive Potential of Adult T-Cell Leukemia Cells through the Endothelium. (2004) (0)
- MEMBRANE EXPRESSION OF NK RECEPTOR KIR3DL2 CONTRIBUTES TO DELINEATE THE ACUTE‐TYPE AND IS A THERAPEUTIC TARGET IN ADULT T‐CELL LEUKEMIA/LYMPHOMA (2019) (0)
- Development of Masitinib for the Treatment of Peripheral T-Cell Lymphoma (2015) (0)
- Therapeutic management and outcome of patients with advanced systemic mastocytosis treated with midostaurin: A comprehensive real‐life study in the French national healthcare database (2022) (0)
- Mast cell activation syndrome: High frequency of skin manifestations and anaphylactic shock. (2019) (0)
- Comparaison of Serum Free Light Chain Measurement with Classical Methods for the Evaluation of Patients with Immunoproliferative Diseases under Treatment. (2005) (0)
- Improving the methodology for the detection of proviral integration sites in the host genome via high throughput sequencing (2015) (0)
- LBA02-11 MASITINIB PLUS DOCETAXEL AS FIRST-LINE TREATMENT OF METASTATIC CASTRATE REFRACTORY PROSTATE CANCER: RESULTS FROM STUDY AB12003 (2021) (0)
- phase 2 study lymphoproliferative disorders: results of a prospective multicenter Efficacy and safety of rituximab in B-cell post-transplantation (2011) (0)
- Heat Shock Protein 70 Cytosolic Sequestration by Excess of Free Alpha-Globin Chains Is a Key Mechanism of the Ineffective Erythropoiesis in β-Thalassemia Major Patients (2012) (0)
- Metabolic Plasticity Reveals a Targetable Vulnerability in Leukemia (2022) (0)
- The Combination of Arsenic Trioxide and Interferon-Alpha Eradicates Leukemia Initiating Cells in TAX-Driven Murine Adult T Cell Leukemia/Lymphoma. (2009) (0)
- Treatment of an aggressive STLV-1 associated lymphoma in a naturally infected baboon (2015) (0)
- Mastocytose pédiatrique : clinique et évolution, une analyse de la littérature de 1597 cas (2013) (0)
- Canonical NF-kB Pathway Is Not Constitutively Activated and May Not Be the Major Bortezomib Target in Mantle Cell Lymphoma (MCL). (2006) (0)
- Whole Exome Sequencing of a Patient with Atypical Congenital Pure Red Cell Aplasia Has Enabled the Identification of a Novel Key Actor of Erythropoiesis That May be Involved in CDAI Physiopathology (2020) (0)
- Régulation de l'érythropoïèse (2001) (0)
- Use of Clofarabine in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in Adults: The French Experience (2011) (0)
- Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases (2005) (0)
- Faculty Opinions recommendation of Hemogenic endothelial fate mapping reveals dual developmental origin of mast cells. (2019) (0)
- Faculty Opinions recommendation of Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. (2014) (0)
- Prognostic Value Of Red Blood Cell and Platelet Transfusion In Elderly Patients With Aggressive Lymphoma Receiving First Line Immunochemotherapy: An Analysis Of The Lysa LNH 03-6B Study (2013) (0)
- Exploring the Deltaretrovirus Tumor Transcriptome: Lessons from RNA-Seq (2014) (0)
- Association of Langerhans Cell Histiocytosis with Erdheim-Chester Disease: How Close Monocyte/Macrophage and Dendritic Cell Lineages Are? (2010) (0)
- This information is current as Regulatory Cells + Foxp 3 SuppressiveHuman Invariant NKT Cells into Converts β Rapamycin Combined with TGF - (2011) (0)
- Prognostic Significance of Complement System Activation After Allogeneic Hematopoietic Stem Cell Transplantation. (2009) (0)
- 11 cases ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of Efficiency of curative and prophylactic treatment with rituximab in (2013) (0)
- Causes and Risk Factors of Early and Late Non-Relapse Mortality after CD19 CAR T-Cell Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Lysa Study from the Descar-T Registry (2022) (0)
- Pegfilgrastim in Congenital Neutropenia: An Observational Survey from the French SCN Registry. (2007) (0)
- Sputum IL-6 Level Is a Potential Predictor and Severity Marker of Acute Chest Syndrome in Sickle Cell Disease (2022) (0)
- Correction to: Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party (2021) (0)
- Étude de comparaison des caractéristiques et de la survie de l’HLH dans une population âgée : OLD HLH (2022) (0)
- Favourable Outcome of B-Cell Non Hodgkin Lymphomas Associated with Hepatitis C Virus - ANRS HC13 LYMPHO-C Observational Study (2010) (0)
- adult T-cell leukemia/lymphoma (ATL) trioxide, interferon alpha, and zidovudine in newly diagnosed chronic Phase 2 study of the efficacy and safety of the combination of arsenic (2012) (0)
- Faculty Opinions recommendation of Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells. (2014) (0)
- Implication des mastocytes dans la physiopathologie de la dépression : exemple de la mastocytose (2014) (0)
- Manifestations gastro-intestinales au cours de la mastocytose (2009) (0)
- Masitinib in mild to moderate Alzheimer’s disease: Results from study AB09004 (2021) (0)
- Combined T reatment W ith A rsenic T rioxide a nd A ll-Trans- Retinoic A cid i n P atients W ith R elapsed A cute Promyelocytic L eukemia (2003) (0)
- In Vivo Assessment of the Next Generation Microtubule-Destabilizing Agent AB8939 in Patient-Derived Xenograft Models of Acute Myeloid Leukemia (2019) (0)
- Can we cure ATL: new drugs and targeting ATL stem cells (2014) (0)
- Rôle de la sérotonine dans la survie du globule rouge : application à la transfusion sanguine (2013) (0)
- Faculty Opinions recommendation of Increased serum levels of matrix metalloproteinase-9 predict clinical outcome of patients with early B-cell chronic lymphocytic leukaemia. (2014) (0)
- [Influenza A: H1N1 post-viral membranoproliferative glomerulonephritis occurring in aggressive systemic mastocytosis: Case report and literature review]. (2021) (0)
- Co-activation of AMPK an d mTORC 1 Induce Cytotoxicity in Acute Myeloid Leukemia Graphical (2019) (0)
- Accessory spleen: Differential diagnosis for lymphoma in autoimmune lymphoproliferative syndrome (2010) (0)
- Phase I/II trial of Arginine Butyrate and ganciclovir in Epstein-Barr virus-associated lymphoid malignancies. (2006) (0)
- Évaluation de l’atteinte cutanée mastocytaire sous Interféron alpha☆ (2012) (0)
- Exploration des déterminants du rendement transfusionnel érythrocytaire dans un modèle murin (2017) (0)
- Allogeneic Hematopoietic Cell Transplantation Is Effective In Patients With Advanced Systemic Mastocytosis: A Multicenter Retrospective Analysis (2013) (0)
- Therapeutic innovations in adult T leukemia/lymphoma (2020) (0)
- Recurrent TET2 mutations in adult T cell leukemia (2014) (0)
- NKp46 Is a Useful Diagnostic Biomarker in Gastrointestinal T-Cell Lymphoproliferative Diseases and Constitutes a Therapeutic Target. a Celac Network Study (2017) (0)
- Effet d’un traitement de jouvence sur la lésion de stockage de culots globulaires (2017) (0)
- Short Communication Regulatory T-Cell Depletion in Angioimmunoblastic T-Cell Lymphoma (2010) (0)
- Diagnostic des mastocytoses sur biopsies cutanées (2021) (0)
- La carence martiale, un vieux sujet réactualisé (2014) (0)
- [Polyarthritis and neutropenia associated with activated clone T CD8 proliferation without large granulous lymphocytes: a new entity different from Felty's syndrome?]. (1996) (0)
- French National Retrospective Cohort of Hairy-Cell Leukemias: Risk of Second Malignancies after 10 Years of Follow-up (2019) (0)
- Genetic of Sporadic Hemophagocytic Lymphohistiocytosis (2019) (0)
- GDF15 and Erythroferrone Mark Erythropoietic Response to ACE-011 (Sotatercept) in Thalassemia (2018) (0)
- What Can We Expect after Performing Allogeneic Stem Cell Transplantation for Adult T Lymphoma in Patients from Romania, Europe? (2019) (0)
- [Weight loss and fever in a 72-year-old man]. (2010) (0)
- Stimulation de l’érythropoïèse au cours de la néphropathie à IgA (2019) (0)
- Arbres décisionnels de l'article : Mastocytoses (2007) (0)
This paper list is powered by the following services:
Other Resources About Olivier Hermine
What Schools Are Affiliated With Olivier Hermine?
Olivier Hermine is affiliated with the following schools:
